Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,14460,64,2.35 [0.56-9.86],0.2446193406683301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,14076,62,0.81 [0.50-1.31],0.3954595105023755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,16459,71,1.78 [1.25-2.52],0.0011970185053651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,13973,61,1.19 [0.61-2.32],0.6073807042894084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,16341,71,1.03 [0.71-1.49],0.8739527108769408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,16459,71,1.19 [0.88-1.61],0.2581929388802185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,14451,64,1.01 [0.86-1.19],0.9159320146867074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,13973,61,0.98 [0.67-1.44],0.93306546931503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16187,69,0.87 [0.66-1.14],0.3081013886399016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14178,64,0.81 [0.53-1.23],0.3270028270556931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14431,63,0.84 [0.64-1.12],0.2346734320941252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,16348,71,1.08 [0.50-2.33],0.8498803066259482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,14451,64,0.71 [0.30-1.63],0.4148875994608171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,16237,71,0.85 [0.55-1.30],0.4474440668652387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,14149,63,1.78 [0.94-3.35],0.074829886736468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,14372,64,0.95 [0.77-1.17],0.6136877290950109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16522,72,0.85 [0.55-1.32],0.4762164751059567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,14009,59,1.34 [0.83-2.15],0.2335149915452843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,16637,73,0.87 [0.46-1.67],0.680132374805841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,16659,73,1.23 [0.88-1.72],0.2280589604052878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,14386,64,0.78 [0.41-1.50],0.4614437273819617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,14009,59,1.13 [0.87-1.46],0.3737772852402073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,13973,61,1.26 [0.73-2.18],0.4097663776003051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",16237,71,1.33 [0.88-2.03],0.1764508307398499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,13973,61,0.82 [0.52-1.28],0.3852687055357007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,16244,70,1.07 [0.58-1.99],0.8328776078320739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,16362,71,2.29 [1.06-4.91],0.034009231874217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,16522,72,0.90 [0.63-1.29],0.5790865031511452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,13973,61,1.21 [0.79-1.86],0.3814245954519444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,14095,61,1.01 [0.69-1.48],0.9477758240916894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,16703,73,1.21 [0.70-2.11],0.4983515666693154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,16472,71,1.30 [0.81-2.08],0.2698518034797604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14009,59,1.88 [1.00-3.53],0.0496285860462525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16237,71,2.83 [1.45-5.51],0.00222854316425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16390,71,2.45 [1.36-4.40],0.0027051631877043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16703,73,1.16 [0.63-2.12],0.6373935031026428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16629,72,3.95 [2.85-5.48],1.5728214442360263e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14372,64,2.47 [1.21-5.02],0.0129431791802536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,14009,59,0.91 [0.40-2.08],0.8223615304473053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16740,73,1.12 [0.46-2.72],0.7954545136089843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16459,71,0.92 [0.56-1.50],0.7332574250923775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16237,71,0.80 [0.38-1.69],0.553279748775842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14009,59,1.32 [0.67-2.61],0.4255691811053033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16598,73,1.31 [0.82-2.08],0.2600536310635529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,14445,64,0.99 [0.48-2.03],0.974223434901436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,14076,62,0.87 [0.30-2.47],0.7881392884258493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,14431,63,0.86 [0.47-1.58],0.6295978095703021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16187,69,0.85 [0.41-1.76],0.6566225028742385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,14149,63,1.14 [0.81-1.61],0.4394290494343161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,16362,71,0.94 [0.50-1.76],0.8408794897950198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,14149,63,0.92 [0.49-1.76],0.8098277534923528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,14372,64,1.45 [0.97-2.18],0.072957708694295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,16601,71,3.19 [1.70-5.98],0.0002981990884048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16679,72,2.72 [1.96-3.79],3.0421387682758422e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,14431,63,0.68 [0.28-1.65],0.3915292205559968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,16459,71,1.06 [0.84-1.35],0.6304672938122611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,16522,72,2.09 [0.96-4.55],0.0637927248823799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,13994,60,0.71 [0.46-1.11],0.1358458765108752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,14149,63,0.95 [0.68-1.32],0.7547006266353891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16237,71,0.88 [0.68-1.16],0.3685940616652051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,14460,64,0.97 [0.68-1.37],0.8587127596279764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,16689,73,1.88 [0.83-4.29],0.132388475349724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,13973,61,1.08 [0.78-1.50],0.6331179576673522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,14149,63,0.93 [0.69-1.26],0.6499526210881946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFM,Afamin,14460,64,0.63 [0.19-2.07],0.4499673908595512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,16337,70,1.51 [1.11-2.07],0.0088824770214352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,13994,60,1.35 [1.04-1.77],0.0266018379227765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,16495,71,1.10 [0.66-1.84],0.7214405764100575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,16025,71,1.11 [0.90-1.37],0.3393023940060976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,16152,69,0.72 [0.49-1.06],0.0968339593593434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,16601,71,0.85 [0.45-1.59],0.6037424938933209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,16703,73,0.79 [0.54-1.18],0.2506148669465892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,14451,64,0.59 [0.36-0.97],0.0366415346641138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,16522,72,0.92 [0.68-1.23],0.5585412878391607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,16522,72,1.00 [0.73-1.37],0.9874371966786386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,14076,62,3.41 [2.16-5.37],1.219087214957421e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,14076,62,1.65 [0.85-3.23],0.1394883411789687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14386,64,0.68 [0.43-1.07],0.098438065404146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,14451,64,1.75 [0.74-4.11],0.2027033350862226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,16516,73,1.18 [0.92-1.52],0.1852990558554166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",14064,63,0.91 [0.67-1.24],0.5537804529868169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,16187,69,0.83 [0.54-1.25],0.371220615545777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,14076,62,0.49 [0.25-0.95],0.0355334578392753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16435,71,1.00 [0.82-1.22],0.9878142139948204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,16522,72,1.04 [0.76-1.44],0.7976506128288421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",14421,64,0.97 [0.77-1.21],0.7667187032305401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,14149,63,2.00 [0.93-4.31],0.0758502897454389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,16187,69,1.02 [0.76-1.36],0.8909474326905564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,14064,63,0.94 [0.63-1.40],0.7694989407499028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,16237,71,0.56 [0.34-0.94],0.0278935323754773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,14009,59,0.83 [0.55-1.24],0.3541656337544818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,16155,71,1.04 [0.75-1.43],0.8261665182521067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,14413,64,0.96 [0.80-1.16],0.6905867238935917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,16120,69,0.85 [0.58-1.25],0.420882048607997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,16740,73,14.39 [5.73-36.15],1.4106362277625776e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,16551,73,1.22 [0.85-1.76],0.2781571479081191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",14386,64,0.91 [0.55-1.51],0.7211497371136902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16462,71,0.92 [0.66-1.27],0.6049474191176207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14413,64,1.41 [0.90-2.21],0.1364977650788067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,14178,64,1.47 [1.01-2.15],0.0466879832062488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,14009,59,0.87 [0.71-1.07],0.1929364695503465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",16459,71,0.92 [0.74-1.14],0.4348649488861854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,16244,70,1.59 [1.03-2.46],0.037311060127934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,16661,73,0.99 [0.35-2.78],0.9790175509735322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14445,64,1.20 [0.47-3.04],0.7002101383519674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,16155,71,0.97 [0.68-1.36],0.8402238390677528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,14064,63,0.89 [0.52-1.51],0.6568701292513767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,16459,71,1.23 [0.50-3.03],0.6533960427472812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,16244,70,0.95 [0.60-1.50],0.8141123489134201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,14149,63,1.21 [0.64-2.30],0.551569419829036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,14329,64,0.87 [0.51-1.48],0.6001526157378534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,14421,64,1.45 [1.05-2.00],0.0234561894141103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13498,61,0.76 [0.45-1.30],0.3156075730593789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,15878,69,0.84 [0.54-1.32],0.4514576420658436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,15408,67,0.80 [0.51-1.26],0.3301888478289985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,16528,71,0.49 [0.25-0.96],0.0368084193170599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,16460,71,0.80 [0.63-1.02],0.0756882617100817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,16689,73,1.40 [0.82-2.40],0.21590337693886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,16299,71,0.94 [0.45-1.97],0.878804088293472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,16547,71,1.23 [0.73-2.09],0.4370201773975745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,16566,71,1.34 [0.74-2.45],0.3372113244298225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,16576,71,0.82 [0.51-1.33],0.4286425595526378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,16689,73,0.89 [0.50-1.59],0.6939247464493592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,13973,61,0.83 [0.56-1.24],0.3735964551252303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,14009,59,1.01 [0.74-1.39],0.9380600361121094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,13939,61,0.80 [0.50-1.28],0.3576658295777596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,16187,69,1.04 [0.72-1.49],0.8326259591841563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14076,62,0.40 [0.16-1.00],0.0490212538359233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,16606,72,0.84 [0.38-1.84],0.6652621574413309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,14072,61,1.11 [0.64-1.90],0.7124604840027005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,16155,71,0.89 [0.68-1.17],0.4017292158059036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,16472,70,0.83 [0.61-1.12],0.2260339063596146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,13856,60,1.71 [1.37-2.13],1.5640510877370888e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,16629,72,0.84 [0.63-1.14],0.2680890157683498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,16451,72,0.88 [0.65-1.18],0.399026972414062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,16105,71,0.90 [0.44-1.83],0.7676866796205777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],16244,70,0.61 [0.37-1.02],0.0574382244881307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,16627,72,1.12 [0.56-2.26],0.7493289763156292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,14386,64,0.98 [0.73-1.33],0.9176215169711386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,14064,63,1.13 [0.69-1.85],0.6231985477817232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,14372,64,1.05 [0.77-1.43],0.7695578670476536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,14421,64,1.00 [0.61-1.66],0.987751670983268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16459,71,1.76 [1.26-2.45],0.0009051432645577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,14312,64,0.69 [0.34-1.39],0.2951854019146529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16630,73,2.88 [2.31-3.60],8.049033183838222e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,16522,72,1.55 [1.05-2.30],0.0274822304115265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,14460,64,0.51 [0.19-1.36],0.1778326207156814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,14451,64,1.24 [0.77-1.99],0.3871838286572888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,14460,64,0.89 [0.44-1.83],0.7597489541058238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,14451,64,1.50 [0.52-4.28],0.451694727153019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,14076,62,0.55 [0.32-0.94],0.0278223089458168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,14433,64,0.57 [0.29-1.15],0.1187442038003207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,13834,60,0.89 [0.47-1.70],0.7240592866061057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,14460,64,0.85 [0.56-1.29],0.4524063115755249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,14451,64,0.89 [0.34-2.34],0.8122465611010344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,16551,73,0.81 [0.45-1.46],0.4916724855178638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,14451,64,0.67 [0.41-1.10],0.1169103158945862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16597,72,0.54 [0.26-1.11],0.0960534202807572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,16535,73,0.70 [0.51-0.97],0.032681908288718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,14149,63,0.87 [0.71-1.08],0.2191568981912141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,16355,69,1.93 [1.19-3.15],0.0081899271391948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,14178,64,0.82 [0.56-1.20],0.3083936157362422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,16459,71,0.82 [0.47-1.43],0.4816648352768845
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,14372,64,1.04 [0.83-1.31],0.7033555928955708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,14413,64,0.95 [0.67-1.36],0.7971851462586954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,16452,71,1.51 [1.01-2.26],0.0444590284096401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",14386,64,0.93 [0.52-1.67],0.8075058799276298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,16187,69,1.04 [0.65-1.66],0.8737072175798954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,16187,69,1.68 [1.30-2.17],7.910178546948504e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,14178,64,1.10 [0.64-1.88],0.7359793098200166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,14149,63,0.88 [0.65-1.19],0.3942085833139402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,13939,61,0.78 [0.54-1.13],0.1927775180373828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,14421,64,1.04 [0.80-1.37],0.7565082905478573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,14413,64,0.98 [0.76-1.27],0.8962749869126082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,16497,71,0.90 [0.73-1.10],0.2956628710888747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,13994,60,0.72 [0.48-1.06],0.0981593982909119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,13994,60,0.77 [0.39-1.50],0.4427596764819349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,16155,71,1.70 [1.32-2.20],4.519362400275611e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,13973,61,0.94 [0.65-1.36],0.7538803548716341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,13973,61,1.05 [0.57-1.93],0.8741818833181476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,13994,60,0.91 [0.58-1.42],0.6812224680828947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,16244,70,0.76 [0.40-1.44],0.3991690142274172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,13973,61,0.82 [0.47-1.42],0.4718565767445901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,16551,73,0.77 [0.48-1.26],0.3015870312410112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,16459,71,0.78 [0.52-1.15],0.2103121092863816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,16627,72,1.77 [1.00-3.15],0.0504615969823223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,13994,60,0.85 [0.53-1.35],0.4811850066763702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,16244,70,1.26 [0.87-1.82],0.2303080538598401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,14296,62,1.04 [0.62-1.76],0.8812583132735432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,16390,71,0.99 [0.67-1.47],0.9531792326878632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,16390,71,1.29 [0.64-2.60],0.4823871769191054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,14451,64,0.98 [0.40-2.43],0.9696572143003832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,14431,63,0.35 [0.14-0.91],0.030765307169286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,14413,64,1.02 [0.71-1.47],0.8958881568223088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,14076,62,0.95 [0.74-1.21],0.6726861634631889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,13973,61,0.76 [0.54-1.07],0.112114991417342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,16155,71,1.07 [0.80-1.43],0.6631314605833836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,13939,61,1.20 [0.62-2.36],0.5864219713010042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,14372,64,1.01 [0.76-1.35],0.9245364462648508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,16187,69,1.39 [1.00-1.94],0.0533419454950727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,16598,73,1.14 [0.85-1.54],0.3789308906081806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,13973,61,0.98 [0.57-1.67],0.9385520776436244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,13973,61,1.11 [0.53-2.32],0.7914043455815458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,13973,61,0.80 [0.40-1.61],0.530503120497816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,13939,61,0.79 [0.42-1.48],0.4575094635282363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,13973,61,1.04 [0.71-1.52],0.8568352742397374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",13973,61,1.06 [0.68-1.63],0.8022699236265046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",16601,71,0.90 [0.74-1.08],0.2513913909710472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",16155,71,1.24 [0.83-1.85],0.3020993885010613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,16187,69,1.34 [0.88-2.05],0.1685543520181429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,16459,71,1.43 [0.74-2.78],0.2864727490397912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,16126,71,0.93 [0.67-1.29],0.6680505994080199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,14076,62,0.95 [0.68-1.34],0.7809046064004752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,13973,61,1.03 [0.80-1.33],0.810300651744408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,14372,64,1.76 [1.03-3.01],0.0403123969500486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",14460,64,2.82 [0.68-11.71],0.1541560232142948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,16155,71,1.15 [0.86-1.56],0.3451692446044337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,13994,60,0.85 [0.65-1.12],0.2410891738421728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,14413,64,1.07 [0.66-1.73],0.7938434963519915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,14421,64,1.32 [0.91-1.92],0.1377269800608615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,16497,71,0.95 [0.76-1.19],0.6742647545647059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,16627,72,1.17 [0.54-2.52],0.6835674779426584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,14413,64,1.32 [0.88-1.97],0.1848713774484329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,16024,69,1.03 [0.78-1.36],0.8275870211588028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,14460,64,1.35 [0.77-2.37],0.2898156460165523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,13973,61,0.93 [0.28-3.11],0.9042374083512148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14076,62,0.75 [0.39-1.46],0.4023814778828261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",16601,71,8.12 [4.58-14.40],8.02382473427078e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",16551,73,1.43 [0.61-3.32],0.4105317156669998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,14009,59,1.04 [0.45-2.39],0.9224336182711784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,16497,71,0.97 [0.72-1.29],0.8137151888099815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,16362,71,0.71 [0.44-1.13],0.1474305193405101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,14009,59,1.57 [1.04-2.38],0.0323553008435097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,16237,71,1.27 [0.71-2.27],0.4161465455865768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16187,69,1.00 [0.71-1.41],0.9849290002645276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,16187,69,1.24 [0.60-2.56],0.5679586139789712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,16497,71,1.09 [0.89-1.33],0.4283920554445394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,14421,64,1.80 [1.54-2.11],2.0894607462833442e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,14064,63,1.06 [0.82-1.37],0.6623306200064634
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,16132,71,0.99 [0.78-1.25],0.9130639472741692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,16551,73,2.46 [1.15-5.24],0.0202179238257054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,16390,71,1.06 [0.57-1.95],0.8559982019771155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14431,63,0.74 [0.32-1.73],0.4932108650474491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",13994,60,0.69 [0.39-1.24],0.2153397147435609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,14180,62,0.81 [0.34-1.95],0.6401191528822399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14372,64,2.16 [1.81-2.58],1.0858092586238879e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,14421,64,0.96 [0.75-1.22],0.7187219664252346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16497,71,1.33 [0.78-2.28],0.2893688925929476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,14009,59,0.82 [0.51-1.33],0.422605716401391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,13939,61,0.62 [0.39-1.00],0.0481359965231314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,14386,64,1.35 [0.93-1.95],0.1126408595139557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,16497,71,0.95 [0.75-1.20],0.6620182812429942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,14445,64,0.69 [0.53-0.90],0.0055096580689323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,14076,62,1.17 [0.79-1.76],0.4335964225682198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,13939,61,0.88 [0.49-1.59],0.6720014795088556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,14445,64,0.83 [0.63-1.09],0.1836737576391242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,16155,69,1.21 [1.01-1.43],0.0338034186804482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,13994,60,1.00 [0.70-1.42],0.9815163965547457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,13973,61,0.57 [0.22-1.45],0.2391610996374676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,16497,71,0.98 [0.71-1.34],0.8964849854579974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,16551,73,0.94 [0.75-1.18],0.5988919079519687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,16187,69,0.77 [0.54-1.10],0.154711023119128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,16740,73,1.05 [0.54-2.05],0.8896493609520796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,14009,59,3.47 [2.93-4.12],1.165487191057076e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,13994,60,0.75 [0.51-1.13],0.1687734915492311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14421,64,0.98 [0.54-1.79],0.9475186437226096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,16551,73,1.41 [1.07-1.86],0.0137362109459301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,14149,63,1.16 [0.50-2.69],0.7289039562331303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,16362,71,0.97 [0.62-1.53],0.901572043147633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,16218,71,0.68 [0.41-1.12],0.1316666992431318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,14149,63,1.74 [0.62-4.90],0.2947983659684711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14431,63,0.87 [0.42-1.81],0.7169238204166593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14009,59,2.49 [1.65-3.75],1.267969561092994e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,16237,71,1.39 [0.56-3.44],0.4750889833469273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,13994,60,1.25 [0.82-1.91],0.2892746705442369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,14076,62,1.11 [0.70-1.75],0.6643965665164424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,13587,60,1.06 [0.84-1.33],0.6396483629036573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,16495,70,0.75 [0.54-1.04],0.0835465130359965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,14402,63,0.80 [0.54-1.18],0.2654740370916086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,14238,64,1.08 [0.86-1.35],0.5219547670574197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,14178,64,1.27 [0.62-2.60],0.5076721073776436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,13994,60,1.60 [1.02-2.52],0.039989710085667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,13973,61,0.83 [0.47-1.47],0.5228468605579399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,13973,61,1.40 [0.75-2.64],0.2906090096310343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,16155,71,0.92 [0.57-1.49],0.7278778299403927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,13994,60,1.35 [0.89-2.06],0.1563509614920844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,14413,64,0.90 [0.47-1.74],0.7543362634059482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,16678,73,2.18 [0.80-5.97],0.1277477542804207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSND,Barttin,13939,61,0.72 [0.32-1.64],0.4354084187699214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16661,72,1.00 [0.65-1.55],0.998569695899652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,16661,72,1.08 [0.71-1.64],0.704767281212485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,16187,69,0.69 [0.50-0.96],0.0275274789367235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,14460,64,0.77 [0.24-2.41],0.6475219626693017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,13939,61,0.86 [0.61-1.21],0.3906918887900764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,14356,64,0.81 [0.40-1.62],0.5483320178083828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,16601,71,2.42 [1.20-4.90],0.0139465117639913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,16497,71,1.42 [0.85-2.38],0.1784956746037874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,13939,61,1.06 [0.59-1.88],0.8503008780755383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,16155,71,0.95 [0.67-1.34],0.7725510618327687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,13973,61,0.86 [0.39-1.90],0.7089181499722947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,16625,73,2.15 [0.89-5.19],0.0901151015628984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14413,64,0.84 [0.55-1.29],0.4282866320085778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,14009,59,0.44 [0.23-0.85],0.0138177373789589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16627,72,1.00 [0.61-1.63],0.993899136529242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14149,63,0.89 [0.46-1.75],0.7444385083213132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14413,64,1.33 [0.69-2.57],0.3910515304229346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14122,63,1.38 [0.80-2.37],0.2464614503910503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,14460,64,0.57 [0.13-2.51],0.4547360333554581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,14429,64,2.88 [0.81-10.26],0.1023408028851941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,14460,64,0.77 [0.25-2.39],0.6466529986505116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,16597,72,0.41 [0.21-0.79],0.0081143891539773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,16126,71,0.87 [0.52-1.46],0.6061143145872848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,14064,63,1.02 [0.68-1.55],0.9103626431170838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C3,Complement C3,13702,60,0.61 [0.31-1.19],0.1474226798254126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,16598,73,0.91 [0.53-1.56],0.739621645918597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C5,Complement C5,14460,64,1.99 [0.44-8.92],0.3682097355630932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,14092,64,2.07 [0.97-4.40],0.0600125835619219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,14421,64,3.03 [2.36-3.91],8.181618405133747e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,14460,64,0.59 [0.27-1.30],0.1898605697931802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,14451,64,1.40 [0.89-2.21],0.1481979258451717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,14372,64,1.36 [1.03-1.80],0.0295910452773784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,16214,71,1.51 [1.07-2.14],0.0200136417552158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,16187,69,1.02 [0.51-2.03],0.952563278530566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,16459,71,1.20 [0.63-2.30],0.5785518893966105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,16354,71,0.89 [0.73-1.09],0.272187036016798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,16689,73,1.49 [0.84-2.66],0.1746857025126108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,16486,71,1.27 [0.95-1.70],0.1083772152881411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,16718,73,1.30 [0.94-1.81],0.1118402029769122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,16740,73,1.60 [0.67-3.79],0.2890065766394828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",16237,71,0.88 [0.69-1.13],0.3309655272299449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,16498,73,0.80 [0.57-1.11],0.1804686135839355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,14178,64,0.94 [0.46-1.91],0.8647863645820992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,14009,59,1.51 [0.81-2.81],0.1896749954531923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,16689,73,0.81 [0.52-1.26],0.3541793540372731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,14064,63,0.97 [0.66-1.42],0.8752059578894089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,13994,60,0.85 [0.38-1.92],0.6942575380106385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,13973,61,1.14 [0.80-1.64],0.4638543405763375
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,13994,60,0.95 [0.62-1.46],0.8248706098157651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14413,64,0.99 [0.74-1.32],0.9316793427249142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,14125,63,0.93 [0.73-1.18],0.5402621773564376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,14064,63,0.85 [0.44-1.64],0.6273275393636448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,16459,71,1.47 [0.91-2.36],0.1126994778306975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,16155,71,0.58 [0.27-1.26],0.1666189144128431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,16361,71,0.80 [0.56-1.14],0.2201608543753221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,14421,64,0.90 [0.47-1.71],0.7448152687775055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16632,73,0.99 [0.81-1.22],0.9522910043355444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14076,62,1.15 [0.84-1.59],0.379022480197025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,13973,61,0.55 [0.25-1.22],0.1422021302901485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16187,69,1.30 [0.82-2.06],0.2707882940946509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14064,63,0.65 [0.38-1.11],0.1167458905631748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14413,64,0.99 [0.79-1.24],0.9240279062920104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,16462,72,10.31 [3.88-27.36],2.8050365202483223e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,16419,71,1.54 [1.11-2.13],0.0096102033411886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,14386,64,0.62 [0.29-1.32],0.2110939312704351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,14421,64,0.84 [0.61-1.16],0.2853429114206481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,16155,71,1.28 [0.87-1.87],0.2048749757001687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,14064,63,0.97 [0.53-1.75],0.9077225385337464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,16155,71,0.96 [0.70-1.30],0.772000408803158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,16155,71,0.94 [0.70-1.27],0.6978279060786187
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,16497,71,0.88 [0.64-1.21],0.4317333820820347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,16740,73,0.92 [0.73-1.17],0.5097805560768865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,14178,64,0.74 [0.61-0.90],0.002874000976846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,14421,64,0.96 [0.72-1.28],0.7779809619851896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,16631,73,1.26 [0.93-1.72],0.1408938922005718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,14009,59,1.19 [0.82-1.74],0.3566756157177386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,13973,61,0.42 [0.19-0.90],0.0255775211627348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAT,Catalase,14240,62,1.28 [0.84-1.96],0.246659596275246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,16496,72,0.78 [0.62-0.98],0.0350155637371575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,13994,60,0.71 [0.49-1.05],0.0863622662106618
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,16689,73,1.19 [0.66-2.16],0.5681811911554585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,14076,62,0.95 [0.57-1.58],0.8473832347018156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,13973,61,0.66 [0.30-1.48],0.3178538780987291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16390,71,1.08 [0.81-1.44],0.5959991467537732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,14421,64,1.35 [1.02-1.80],0.0375742389387047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,14386,64,0.75 [0.44-1.26],0.2716710435550458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,14064,63,1.41 [0.62-3.21],0.415407145555264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,14413,64,1.56 [1.30-1.88],2.076498038612272e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,16522,72,0.94 [0.53-1.70],0.8462579681744922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14076,62,1.31 [0.90-1.91],0.1538134217205898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,16703,73,0.63 [0.37-1.06],0.0793718716969226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,16676,73,0.76 [0.56-1.04],0.0866686621075371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,16528,71,0.85 [0.49-1.46],0.5504783993983291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,16740,73,0.95 [0.59-1.55],0.8508424500890455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,16740,73,1.16 [0.77-1.76],0.4778860428126193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,16512,71,0.72 [0.57-0.92],0.0070098031686556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,16328,71,1.04 [0.77-1.40],0.8022373411109275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,16661,72,1.02 [0.87-1.20],0.8210309827719774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,16362,71,1.32 [0.90-1.93],0.1597698742875989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,16703,73,0.85 [0.66-1.10],0.2197067409084833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,16601,71,0.90 [0.52-1.55],0.6963167934655674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,16387,71,0.79 [0.52-1.20],0.2704035472421613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,16601,71,0.92 [0.55-1.53],0.7352222972401725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,16576,71,0.90 [0.70-1.17],0.436751032614567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,16703,73,0.73 [0.47-1.13],0.159357606189982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,16497,71,0.76 [0.59-0.98],0.0378859105418275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,16522,72,0.79 [0.55-1.12],0.1773285217324628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,16432,71,0.72 [0.48-1.07],0.1024840570853914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16497,71,1.56 [1.33-1.84],5.9433372059137014e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,16563,71,1.28 [1.02-1.61],0.0324195201175335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,16627,72,0.73 [0.59-0.89],0.0021026319619665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,16497,71,0.72 [0.47-1.09],0.1195977102777768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,16661,73,0.75 [0.54-1.04],0.0878043845708672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,16427,71,0.63 [0.48-0.82],0.0006856308234829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,16515,69,0.47 [0.31-0.70],0.0002483802527128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,16711,73,1.26 [0.69-2.30],0.457375457781625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,16689,73,0.86 [0.50-1.47],0.5741145739893826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,16551,73,1.53 [0.90-2.60],0.1165170550186246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,14178,64,3.22 [1.61-6.43],0.0009353716064758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,14009,59,1.12 [0.89-1.41],0.3223077211986986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,16390,71,1.36 [0.88-2.09],0.1656957211435404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,16187,69,1.14 [0.73-1.79],0.5646110464229437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,14372,64,1.00 [0.58-1.72],0.9955196023317626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,16551,73,0.81 [0.44-1.51],0.5106663360725775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,16248,71,1.42 [0.86-2.33],0.1688272794929888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,16703,73,0.84 [0.54-1.31],0.4441552683828004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,16627,72,1.79 [1.13-2.82],0.0123669558160106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,16551,73,1.13 [0.55-2.31],0.7385235801349145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,14064,63,1.00 [0.51-1.95],0.9986540379452152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,16525,73,1.32 [1.10-1.58],0.0031392646587364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,16598,73,4.21 [1.81-9.81],0.0008401463169029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,13973,61,1.11 [0.63-1.95],0.7285932806120541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16497,71,19.73 [10.82-35.96],2.1631766578548463e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,16444,71,1.63 [0.93-2.87],0.0883464435292766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,16142,70,0.83 [0.48-1.44],0.5093875512293647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,16593,73,1.10 [0.64-1.87],0.7345990921082145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16703,73,2.64 [2.10-3.33],1.152938918022357e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,14009,59,0.52 [0.28-0.96],0.0363053474630649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,16703,73,0.84 [0.39-1.80],0.6578160540643865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,14445,64,1.35 [0.75-2.44],0.3177340565349575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16598,73,6.21 [4.56-8.46],4.649703273606035e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,16390,71,1.47 [0.83-2.60],0.1826989340263795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,16522,71,0.83 [0.47-1.48],0.5285934422852518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16187,69,2.19 [1.65-2.89],4.0858683038661664e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,16522,72,1.22 [0.89-1.69],0.215139416013482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,14149,63,2.94 [1.42-6.11],0.003805898220956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,16661,72,1.74 [0.99-3.08],0.0561052486131856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,16630,72,1.31 [0.80-2.15],0.2773958058643516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,16689,73,1.41 [0.96-2.07],0.0755379483320916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,16551,73,1.30 [0.75-2.25],0.347380110954914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,16459,71,1.57 [0.82-3.01],0.1746854725001066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,16598,73,0.91 [0.71-1.17],0.4827016597832377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,16614,72,2.00 [0.86-4.67],0.1090714620227842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,14009,59,0.84 [0.47-1.50],0.5521045963815578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16459,71,0.77 [0.40-1.48],0.4244789471190358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,13994,60,1.12 [0.56-2.24],0.7580305659116264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,14178,64,1.07 [0.59-1.95],0.8181587052189148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,14009,59,0.81 [0.56-1.18],0.2685861614780035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,16467,71,1.04 [0.52-2.08],0.9108871057281543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,16538,71,0.94 [0.61-1.46],0.7973238968434315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,16703,73,0.76 [0.59-0.99],0.0427509547695296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,16478,71,2.71 [1.54-4.76],0.0005197055121857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16576,71,18.93 [11.78-30.44],6.409263407182191e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16661,73,5.63 [4.68-6.77],1.0290349159243162e-74
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,15981,70,1.87 [0.92-3.78],0.0814167052445604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,16505,71,1.62 [0.49-5.37],0.4267891515634685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,15975,66,2.52 [1.20-5.28],0.0145057861941085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,14383,62,0.31 [0.18-0.53],1.5791184126998264e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,16678,73,5.07 [3.57-7.20],9.746371570158089e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,16362,71,0.68 [0.45-1.02],0.0634542879133894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,16466,72,0.91 [0.72-1.16],0.4541328586642477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,13977,59,1.58 [0.96-2.60],0.0690696016394061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16497,71,7.10 [5.37-9.39],4.060435431323324e-43
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14149,63,9.97 [7.15-13.92],1.0466285246569959e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16661,72,6.69 [4.40-10.17],6.464410280000144e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16703,73,6.38 [5.14-7.93],3.248102351286068e-63
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14431,63,11.55 [7.47-17.87],3.561785795111161e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,14178,64,0.71 [0.35-1.43],0.3369546522515932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16497,71,5.42 [3.41-8.62],9.947918111630062e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,16497,71,0.58 [0.30-1.13],0.1124342200362099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,14372,64,4.47 [2.57-7.78],1.1543709214732721e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,16661,72,1.64 [1.15-2.34],0.0060869852225666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,15954,71,1.65 [0.86-3.17],0.1346101769884217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,16551,73,1.35 [0.47-3.88],0.5725319453434763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,16551,73,0.96 [0.41-2.28],0.9310911396385048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,14401,61,0.63 [0.36-1.10],0.1039515385630645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,14421,64,1.41 [0.62-3.22],0.4171561660129251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,13939,61,1.11 [0.78-1.58],0.5630147630751432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,13939,61,0.59 [0.28-1.21],0.1482442759394361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,14342,64,1.03 [0.73-1.46],0.8519287522211025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,16187,69,1.42 [1.04-1.94],0.0295662150026957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,16598,73,1.04 [0.81-1.33],0.7833698939221654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,14372,64,0.95 [0.75-1.21],0.7021886190906048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,16390,71,1.50 [1.05-2.14],0.0247948286036925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,16012,70,0.75 [0.41-1.37],0.3456376144947033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,16632,72,0.66 [0.45-0.95],0.0241857640482259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,16522,72,0.67 [0.48-0.94],0.0187297349958796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,16522,72,1.36 [0.76-2.43],0.3026391530689744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,14178,64,0.63 [0.25-1.59],0.3267115694891007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,14421,64,1.10 [0.46-2.67],0.8278769150738226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,16661,72,1.93 [1.14-3.26],0.0145317159919423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,13994,60,0.72 [0.40-1.31],0.285322261864023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,16740,73,2.10 [1.11-3.99],0.0233346140263954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,16522,72,1.58 [0.94-2.68],0.0851061853414105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,16155,71,0.72 [0.42-1.26],0.2552340886454975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,16459,71,0.97 [0.71-1.33],0.8510090098366484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,16522,72,1.22 [0.70-2.12],0.4860220458200633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,13939,61,1.58 [0.82-3.05],0.1750677254860091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14413,64,0.73 [0.46-1.16],0.1858898436325037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,13994,60,0.80 [0.46-1.37],0.4166967021069371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,16459,71,0.87 [0.71-1.06],0.1736069541838958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16459,71,0.85 [0.69-1.05],0.134213781705498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,16459,71,1.25 [0.68-2.28],0.4691690755499462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16550,71,0.63 [0.28-1.39],0.2516257940171581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,16652,72,1.04 [0.64-1.68],0.8698708234296663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16571,73,1.64 [0.60-4.50],0.3360008253084574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14372,64,1.17 [0.86-1.59],0.3235457820792605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14178,64,0.57 [0.33-0.98],0.0436960386565394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14372,64,0.82 [0.45-1.49],0.5096824201698337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14178,64,0.83 [0.46-1.51],0.5479705846007078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16497,71,1.27 [1.01-1.60],0.0410474328924546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16187,69,0.63 [0.38-1.05],0.0761496176557209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,15999,69,1.01 [0.71-1.43],0.9685838934319636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14445,64,0.61 [0.31-1.19],0.1456790564197365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16237,71,1.19 [0.78-1.80],0.4230126528790007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,14009,59,0.75 [0.32-1.75],0.5028077842158787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,16237,71,0.96 [0.55-1.68],0.8884079417338614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,14445,64,0.91 [0.62-1.33],0.6163056267697095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,16716,73,1.04 [0.73-1.47],0.8394739694990062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14149,63,0.59 [0.25-1.39],0.2294438673484605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,14009,59,1.48 [0.83-2.62],0.185579490600066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,13994,60,0.78 [0.46-1.32],0.350511719958429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,14178,64,1.36 [0.93-2.00],0.1173153893124482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,14178,64,1.12 [0.82-1.52],0.4757874878693328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,13973,61,0.45 [0.19-1.04],0.0615792272559945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,13939,61,0.82 [0.44-1.54],0.5379457991256997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,16244,70,1.15 [0.87-1.51],0.324596723392496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,14076,62,0.87 [0.62-1.23],0.4343902928917867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,16187,69,0.87 [0.64-1.16],0.3428345049969448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,14178,64,0.83 [0.50-1.37],0.4662637108805466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,13939,61,1.04 [0.55-1.97],0.910489156308429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,16114,71,1.17 [0.87-1.59],0.2972233560152647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,16187,69,1.28 [0.94-1.76],0.1226372547603022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,16155,71,0.99 [0.70-1.40],0.9538877888968512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,16589,72,1.03 [0.80-1.32],0.8263449067798756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,16459,71,0.73 [0.49-1.10],0.1368260992008637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,16459,71,0.85 [0.62-1.18],0.3318640576175011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,16155,71,1.05 [0.77-1.44],0.7396481806408526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,14372,64,1.02 [0.74-1.39],0.9229982179677804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,14201,60,1.67 [0.77-3.65],0.1950745223473762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,16187,69,0.92 [0.57-1.50],0.7385779603669202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,14460,64,0.87 [0.26-2.86],0.8158682831000094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,13611,58,1.12 [0.37-3.42],0.8421510747997154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,14356,64,0.96 [0.64-1.46],0.8660955952134299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,14434,64,1.21 [0.86-1.71],0.281668853302613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,14253,62,0.62 [0.38-1.01],0.0549476202851928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,14460,64,1.46 [0.42-5.03],0.5471438464938744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFP,Properdin,14460,64,1.38 [0.62-3.09],0.4332870208935061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,16551,73,1.06 [0.76-1.47],0.7399980674224061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14451,64,1.35 [0.71-2.57],0.3608026890103549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,14064,63,0.91 [0.48-1.75],0.7879066532158081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,16522,72,1.22 [0.75-1.99],0.4199771886329797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16187,69,1.18 [0.84-1.66],0.3383785184105812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,14149,63,0.64 [0.40-1.04],0.0714258418401741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14421,64,2.31 [1.63-3.28],2.2760132885815976e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,14386,64,1.43 [0.69-2.98],0.3391509633295831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,16237,71,1.00 [0.53-1.91],0.997072562285906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,14445,64,0.90 [0.68-1.19],0.4529419166708608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,16608,72,1.28 [0.78-2.11],0.3292568694848796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,16228,71,1.00 [0.77-1.29],0.986321101168464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,16625,72,1.08 [0.92-1.26],0.3544720268549538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,16606,72,1.78 [0.94-3.35],0.0745876050449565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,14064,63,0.93 [0.62-1.39],0.7102800748316629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,16390,71,0.84 [0.65-1.10],0.2033100708304462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,14431,63,0.78 [0.50-1.21],0.2675044405052702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,13994,60,0.72 [0.48-1.08],0.1149002822072301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,16576,71,1.17 [0.60-2.28],0.6542382229413093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,16522,72,1.12 [0.71-1.75],0.6323182860575557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,14064,63,0.82 [0.39-1.71],0.5949945973934176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,16598,73,1.02 [0.73-1.43],0.9201149423689672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,14445,64,1.08 [0.69-1.70],0.7256604948775016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,14178,64,1.06 [0.63-1.78],0.8210138992691269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,14372,64,1.03 [0.80-1.33],0.7956191020835512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,14064,63,1.61 [1.07-2.42],0.0209711617789559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16640,73,3.05 [2.13-4.37],1.2922055675869623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,14445,64,1.24 [0.82-1.87],0.3133681194920244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16493,71,0.92 [0.68-1.24],0.576916946293438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,13939,61,1.09 [0.81-1.48],0.5644560937121192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,16493,72,0.78 [0.56-1.10],0.1514870149226526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,16390,71,1.13 [0.63-2.03],0.6895170908068888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,16522,73,0.55 [0.36-0.83],0.0042441328296802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,14009,59,4.82 [2.94-7.89],4.147158445942627e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,16551,73,1.56 [0.84-2.90],0.1567442584838412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,16237,71,1.46 [0.79-2.69],0.2272033781508793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,16661,72,0.85 [0.68-1.06],0.1550052103260387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,14064,63,1.04 [0.66-1.64],0.8769956074996641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,14109,60,1.45 [0.46-4.52],0.5247832264590839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,16497,71,1.21 [0.66-2.22],0.5401912059228691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,16497,71,2.19 [1.48-3.26],0.0001051723540002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,16497,71,1.17 [0.83-1.65],0.3584617201286434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,16497,71,1.10 [0.58-2.08],0.7649868601829255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,14418,63,0.92 [0.56-1.51],0.7463804980823172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,16485,72,1.34 [0.68-2.67],0.3976085388476031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,16187,69,1.01 [0.64-1.61],0.9504311205903692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,16703,73,1.11 [0.76-1.62],0.581715223677289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,14064,63,0.79 [0.45-1.40],0.4171840407495992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,14064,63,0.59 [0.24-1.44],0.2501272555571219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,13939,61,1.34 [0.93-1.93],0.1192489327820437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,16497,71,0.95 [0.79-1.14],0.5757635586480134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,16689,73,1.95 [0.76-4.97],0.1623511100050291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,14064,63,1.15 [0.58-2.27],0.6936455363107934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16361,71,0.95 [0.76-1.18],0.6299224068460914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,16516,73,1.05 [0.79-1.41],0.7181756516344157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,16126,71,0.83 [0.42-1.64],0.5967769620149261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,16155,71,1.03 [0.70-1.52],0.8932484648752583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,16703,73,1.06 [0.63-1.79],0.831023956091526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,14421,64,3.85 [2.36-6.30],6.994778054453827e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,16237,71,1.03 [0.66-1.61],0.8977475142239628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,14460,64,0.49 [0.13-1.86],0.2919787596165865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,16496,72,1.13 [0.71-1.80],0.613982115096632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,14431,63,0.89 [0.68-1.17],0.4047506468617848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,14386,64,0.89 [0.66-1.19],0.4347138279263545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,16627,72,0.78 [0.51-1.19],0.2444276686350522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,13994,60,0.90 [0.53-1.51],0.68045493691934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14049,62,0.97 [0.71-1.33],0.847797285540762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,16237,71,0.97 [0.67-1.38],0.8488178974082282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,16459,71,0.81 [0.61-1.08],0.1451908429473468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNST,Consortin,16522,72,0.91 [0.75-1.10],0.3221833578016899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,13994,60,1.16 [0.58-2.33],0.6666627884552423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,16740,73,3.24 [1.51-6.94],0.0025259651279701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,16689,73,0.80 [0.50-1.28],0.3492459770759401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,16551,73,0.95 [0.47-1.91],0.8854709033066778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,16551,73,0.75 [0.32-1.78],0.5172014039578335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,16564,72,1.06 [0.60-1.86],0.8464253395619126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,16497,71,1.75 [1.11-2.76],0.0167737410070475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,14064,63,1.07 [0.87-1.31],0.5392606328522622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,14431,63,3.07 [2.02-4.69],1.869138148842972e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,14445,64,1.44 [0.59-3.51],0.4257006295175821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,16629,72,1.70 [0.70-4.11],0.2427048150122358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,16740,73,0.77 [0.33-1.81],0.5433017039627284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,14372,64,0.75 [0.51-1.09],0.1332768595977878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,14064,63,1.21 [0.90-1.64],0.2129294321405004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,14076,62,0.65 [0.46-0.90],0.0107226017877684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,14445,64,0.80 [0.29-2.23],0.6682292914159578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,16522,72,1.70 [1.04-2.80],0.035644488690835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,14153,64,1.27 [0.79-2.05],0.3168745989714987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,14149,63,0.71 [0.37-1.35],0.299572424130731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,16740,73,1.37 [0.78-2.40],0.2756055732178426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,16497,71,0.62 [0.38-1.01],0.0560724732081217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,14178,64,1.54 [1.10-2.15],0.0111925875497912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,16522,71,1.78 [0.83-3.82],0.1399305400170644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,14076,62,1.02 [0.68-1.54],0.915615803733166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,14386,64,1.16 [0.68-1.99],0.590768241052971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,16378,71,1.27 [0.67-2.39],0.4663404507550748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,16077,69,0.97 [0.74-1.26],0.8040862098004902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',13973,61,1.20 [0.72-2.00],0.4770048336523885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,16155,71,0.62 [0.35-1.10],0.1000468665699457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14076,62,0.92 [0.51-1.66],0.7786658125484087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,16194,70,1.12 [0.90-1.40],0.3054278000765258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,13994,60,0.80 [0.39-1.65],0.5389842862059273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16459,71,0.93 [0.68-1.26],0.6318923979465082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,14431,63,1.02 [0.49-2.12],0.9613963508898152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,16740,73,0.90 [0.65-1.25],0.5286077775903699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,16611,72,0.84 [0.61-1.16],0.2997284694491036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,13869,60,1.15 [0.64-2.07],0.6390301914582427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,16740,73,0.89 [0.63-1.26],0.5125035762997487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,14433,64,0.57 [0.20-1.68],0.3100069566303679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,16544,72,1.73 [0.94-3.19],0.0775193764530823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,13939,61,1.14 [0.55-2.36],0.7290881192416285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,16572,72,1.03 [0.56-1.90],0.9264048253773794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",14009,59,1.29 [0.55-3.04],0.5533250152653569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,16661,72,1.14 [0.83-1.55],0.4169918758501064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,14412,64,0.54 [0.29-1.02],0.0584106644804747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,13973,61,0.58 [0.27-1.23],0.1549956538499822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,16668,73,1.90 [1.12-3.25],0.0179788828253989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,16598,73,0.72 [0.53-0.98],0.0341148175274105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,14431,63,1.34 [0.55-3.26],0.5236209980378004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,14397,62,2.77 [1.47-5.20],0.001545499896712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16627,72,2.45 [1.61-3.72],3.0102382180241343e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16187,69,1.02 [0.79-1.31],0.8999185181345255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,16361,71,0.99 [0.75-1.32],0.9587056297837572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,13939,61,0.89 [0.55-1.42],0.6186247783003967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,13939,61,1.73 [0.75-3.96],0.1952906433617361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,16348,73,1.10 [0.65-1.85],0.7326617357017653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,14149,63,1.11 [0.57-2.16],0.7544676340305075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,16576,71,0.97 [0.65-1.46],0.8807925604870609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,16160,68,2.19 [1.75-2.73],5.168766545611215e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,16522,71,1.33 [0.61-2.87],0.4721209607795866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,16237,71,0.83 [0.57-1.22],0.3483100115003765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,16601,71,2.37 [0.88-6.39],0.0896455165081959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,16390,71,0.87 [0.48-1.57],0.6427466199216595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,16689,73,1.23 [0.84-1.78],0.2852871696504486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,14323,64,0.71 [0.30-1.72],0.4516138513060267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,16559,71,0.92 [0.76-1.12],0.4236378516332634
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,16601,71,6.01 [2.61-13.85],2.498826913286996e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,16109,70,1.01 [0.74-1.38],0.9539194954556368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,16740,73,0.74 [0.38-1.43],0.3718761099373059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16390,71,3.78 [2.65-5.39],2.0382933853263722e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,14064,63,0.77 [0.44-1.37],0.3809655234906299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,16237,71,0.79 [0.60-1.03],0.0835521521608964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,14431,63,0.95 [0.65-1.40],0.8109320944192497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,14421,64,0.78 [0.51-1.19],0.2535463638845637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,14421,64,0.97 [0.75-1.24],0.7787275685018792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,13994,60,1.02 [0.73-1.42],0.9203206742494268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,14076,62,0.99 [0.75-1.30],0.941514603707641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,13973,61,1.08 [0.90-1.31],0.3935414270983183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16601,71,4.21 [2.18-8.11],1.7646059412929854e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14451,64,2.62 [1.61-4.28],0.0001164174337456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,13973,61,1.51 [0.87-2.60],0.1394869221371662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16390,71,1.14 [0.82-1.58],0.4439649165768516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,14009,59,1.84 [0.99-3.40],0.0534745645015798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,16244,70,0.98 [0.63-1.53],0.9325851360730404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,14009,59,1.18 [0.51-2.73],0.6935825497550361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,14451,64,1.04 [0.46-2.37],0.9288059154169122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,14009,59,1.27 [0.89-1.82],0.186047507274329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,14413,64,1.77 [1.07-2.95],0.0274851809708709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,14445,64,1.86 [0.90-3.84],0.0945071820907461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,13994,60,1.21 [0.78-1.88],0.4002870976276608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,13973,61,0.80 [0.60-1.07],0.1334990004567185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,12568,55,0.95 [0.73-1.24],0.7214801648614887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,16600,72,1.22 [0.59-2.52],0.5898848498576936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,16215,71,0.96 [0.65-1.40],0.8160095461365064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,16103,70,0.83 [0.54-1.28],0.3914063650294584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,16563,71,1.09 [0.89-1.34],0.3920151727981165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,16315,70,1.87 [1.21-2.90],0.0049221743658509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,14154,64,1.39 [0.92-2.09],0.1195339799214625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,14227,61,0.60 [0.26-1.41],0.2434664474635321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,16237,71,0.80 [0.62-1.04],0.0938527758648184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,14445,64,1.74 [0.79-3.81],0.168298241932181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,14445,64,1.42 [0.75-2.66],0.2811197834810447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,13994,60,0.60 [0.24-1.53],0.2852500981074916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,16551,73,0.81 [0.57-1.17],0.2687411729028595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,16530,71,0.87 [0.63-1.19],0.3791032867516973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,14421,64,0.99 [0.70-1.41],0.9683432807176896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,16573,71,1.58 [1.11-2.27],0.012238052009587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,16501,68,0.85 [0.52-1.40],0.531202040536472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,15496,68,0.81 [0.46-1.44],0.4741748206653741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,14149,63,1.47 [0.93-2.33],0.1001571697254074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,16598,73,0.71 [0.42-1.22],0.2154468089636997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,16178,69,1.08 [0.81-1.44],0.595335899501826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,16522,72,5.11 [2.48-10.50],9.29514195911972e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,16703,73,1.37 [0.70-2.67],0.3588110322339383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,12946,63,2.45 [0.92-6.49],0.0723974995866691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,16634,72,0.67 [0.39-1.14],0.1383313967449388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,16582,72,1.36 [0.71-2.64],0.3548230261714858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,14064,63,1.62 [1.10-2.39],0.0147279273341667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,14279,63,1.90 [1.56-2.32],2.0975839647369714e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,16390,71,1.09 [0.58-2.05],0.7919737811224459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,16497,71,0.78 [0.49-1.23],0.2793252353501552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,16516,69,0.96 [0.77-1.21],0.7302147620559882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,16601,71,0.90 [0.65-1.26],0.5571769384703089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,16661,72,0.78 [0.59-1.05],0.0989423095866234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,16244,70,0.73 [0.42-1.27],0.2661707076977467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16661,72,1.41 [1.15-1.73],0.0009397117755462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,16244,70,0.74 [0.48-1.16],0.1898749937658811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,16720,73,1.03 [0.42-2.52],0.9444307914199856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,16703,73,0.78 [0.45-1.32],0.3513031937786602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,16538,71,0.70 [0.57-0.86],0.0007590613188281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,16472,72,0.74 [0.62-0.89],0.001169379591101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,16703,73,0.92 [0.70-1.22],0.5729615942816985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,16445,73,0.88 [0.64-1.21],0.4246573540837987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16601,71,1.13 [0.83-1.53],0.4532358528319985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,13939,61,0.71 [0.46-1.09],0.1134001091491186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,14219,63,2.80 [2.10-3.73],2.6559063902241785e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",13973,61,0.74 [0.51-1.09],0.1253005701906257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,13939,61,0.94 [0.66-1.34],0.7261495682365121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,14445,64,0.69 [0.26-1.80],0.4472759605800825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,14149,63,0.87 [0.65-1.17],0.3656889215991225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,16689,73,0.91 [0.76-1.10],0.3186465494592807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,16601,71,0.65 [0.41-1.04],0.0738794848612527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,14009,59,0.85 [0.54-1.32],0.4656707939015178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,14009,59,1.02 [0.65-1.59],0.9285919432447708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16497,71,0.95 [0.80-1.12],0.5551472925305847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",16361,71,0.95 [0.71-1.28],0.7541559854705315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,14421,62,1.11 [0.87-1.41],0.4213068970231388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,16480,72,1.11 [0.85-1.45],0.4568616036800506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,14009,59,0.91 [0.54-1.53],0.7192795444026874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,16601,71,0.93 [0.74-1.17],0.5562800455779422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16598,73,1.24 [0.69-2.24],0.471328484454467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,14064,63,1.29 [0.53-3.16],0.579344501837222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,13939,61,1.00 [0.68-1.48],0.98814416992478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,13939,61,1.13 [0.52-2.47],0.7545469242637026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCN,Decorin,16237,71,1.88 [0.79-4.46],0.1546158937140316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,14149,63,0.90 [0.69-1.16],0.4014719862773921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,16689,73,0.96 [0.69-1.32],0.7917464382950489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,16459,71,1.06 [0.84-1.32],0.6297028800146944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,16155,71,0.83 [0.60-1.15],0.2566526668528301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,16522,72,3.71 [2.09-6.59],7.519862465629376e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,13994,60,1.13 [0.85-1.51],0.4102656792123226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,13939,61,0.92 [0.67-1.27],0.6177392548773163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,16598,73,0.97 [0.65-1.45],0.8996741269989033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,13973,61,1.29 [0.76-2.20],0.3455782141934261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16459,71,0.89 [0.54-1.47],0.6522886654249593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,16496,72,1.16 [0.75-1.79],0.5165929619418732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,14413,64,1.02 [0.71-1.48],0.9059889194047102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,14149,63,1.31 [0.97-1.76],0.0807940699974641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,16661,72,4.62 [2.09-10.19],0.0001536325200963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,14445,64,1.54 [0.93-2.55],0.0908313542700672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,14372,64,1.01 [0.62-1.65],0.9632376881987342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,14064,63,0.95 [0.47-1.90],0.8742506977869887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,14009,59,1.61 [0.76-3.41],0.2116443867180425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,14009,59,0.96 [0.59-1.58],0.8786553302871636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,14064,63,1.02 [0.52-1.99],0.961773149824418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,16187,69,1.38 [1.03-1.83],0.030243758739758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16497,71,1.01 [0.81-1.26],0.9222025148329172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,16234,71,0.66 [0.42-1.03],0.0649580980866937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,13893,57,0.87 [0.45-1.69],0.6825554173561315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,13994,60,1.00 [0.63-1.58],0.9962576901638572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,13994,60,0.99 [0.70-1.40],0.9650532734353874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,13994,60,0.73 [0.40-1.31],0.2905436239726648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,16316,70,0.87 [0.75-1.01],0.0726066171466315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,13973,61,0.84 [0.48-1.48],0.5539952785218032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,14009,59,1.02 [0.66-1.59],0.9173245092546832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,16703,73,1.44 [1.08-1.93],0.0135226029674233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,13994,60,1.78 [1.41-2.24],1.3087232847046129e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,14009,59,1.17 [0.75-1.84],0.4889322435099767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,16244,70,0.51 [0.27-0.96],0.0383144065496242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,13973,61,1.03 [0.63-1.70],0.8994826184359552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,14386,64,1.80 [1.34-2.42],0.0001105775138984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14421,64,0.86 [0.50-1.49],0.5906334668072468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",16485,72,0.91 [0.75-1.10],0.3083568988020987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,14064,63,0.95 [0.52-1.74],0.8635989551578345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,14149,63,1.28 [0.55-2.98],0.5707045639058261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,16661,72,0.66 [0.46-0.94],0.0214963043206353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,16740,73,1.50 [0.75-2.98],0.2487458697399819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,16369,71,0.81 [0.50-1.32],0.3978683224001211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,16459,71,1.37 [1.03-1.82],0.0316322503989683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,14421,64,0.88 [0.62-1.24],0.4652586168853655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,14413,64,0.61 [0.30-1.24],0.1708264159800822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,16740,73,1.23 [0.85-1.78],0.2791465604383605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,16598,73,2.03 [1.06-3.89],0.032570371266258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,14076,62,0.48 [0.25-0.89],0.0206823423335179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,14076,62,1.18 [0.75-1.85],0.4639837103882636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,14076,62,0.82 [0.56-1.22],0.3341375118981716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,13939,61,1.17 [0.72-1.91],0.5255175125489111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,16665,73,0.90 [0.70-1.16],0.399396675482405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,14421,64,1.28 [0.93-1.77],0.1271679822710787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,16459,71,0.95 [0.74-1.21],0.6804191486639442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,14372,64,0.92 [0.62-1.35],0.657728917108972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,14149,63,1.11 [0.71-1.74],0.6370414254245469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,14011,60,0.78 [0.58-1.06],0.1123678289357892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,16237,71,0.65 [0.40-1.06],0.0815194949691589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,14421,64,1.16 [0.65-2.08],0.617244398817975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,14076,62,1.05 [0.78-1.41],0.7314113725481637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,14372,64,1.43 [1.06-1.94],0.019656355552053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,16497,71,0.89 [0.39-2.04],0.7850177093853331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,13994,60,0.82 [0.58-1.17],0.2747369591275315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,14372,64,0.80 [0.65-0.98],0.0274920185223583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,14413,64,1.00 [0.64-1.55],0.9904061464211088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,16390,71,1.59 [1.18-2.13],0.0020613943000622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,14421,64,1.26 [0.81-1.94],0.3016091927611915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16584,71,1.26 [0.84-1.87],0.2655389339907538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,14064,63,0.84 [0.40-1.77],0.6463350020389725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,13994,60,0.78 [0.58-1.04],0.0848954320048349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,14421,64,0.96 [0.81-1.15],0.6594343205967055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,16522,72,0.95 [0.80-1.13],0.5361074643500727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,16361,71,1.15 [0.74-1.79],0.5219965353842708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,16459,71,4.09 [2.23-7.49],5.200666219532556e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,16497,71,1.02 [0.57-1.85],0.936994807232806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,16278,70,0.69 [0.32-1.51],0.3554576323757161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,16459,71,0.85 [0.45-1.58],0.5989681060446386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,16398,71,0.71 [0.50-1.00],0.0497223305694663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,16740,73,1.18 [0.51-2.75],0.6969595061767794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,16630,73,1.51 [1.14-2.01],0.0044912629771377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,16390,71,1.35 [0.83-2.19],0.2314615331427886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,16459,71,0.90 [0.61-1.31],0.5702086113988485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,16374,73,1.96 [1.12-3.44],0.0186775618326749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,14413,64,3.13 [1.68-5.84],0.0003230133994164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,16551,73,0.88 [0.41-1.89],0.7384982751055984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,16633,73,1.09 [0.59-1.99],0.7871216507567578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,16404,71,1.06 [0.69-1.62],0.7829742036066325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,14149,63,0.86 [0.65-1.15],0.3151593354238685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,14356,64,1.35 [0.79-2.32],0.2750522877815218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,14064,63,0.73 [0.46-1.18],0.2018319315743213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,16459,71,6.18 [3.62-10.56],2.4307198337797165e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,14431,63,1.00 [0.70-1.43],0.9935868496014428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,16237,71,0.82 [0.58-1.17],0.2737413869853066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,14386,64,0.83 [0.46-1.51],0.5408539521668367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,14064,63,0.87 [0.58-1.31],0.5066918545975505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,16155,71,0.87 [0.66-1.14],0.3116710353456229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14372,64,0.94 [0.74-1.18],0.5783108017327114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,14421,64,1.49 [0.91-2.45],0.1169335505008242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14386,64,0.96 [0.56-1.64],0.871460268383506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,14064,63,1.20 [0.90-1.58],0.2112855590936926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,14386,64,1.16 [0.68-1.98],0.5851555169318272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16390,71,1.04 [0.83-1.30],0.7161663095064301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,16659,73,2.52 [1.32-4.81],0.0052076236888424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,16155,71,0.72 [0.39-1.32],0.2870887099787502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14431,63,0.93 [0.65-1.31],0.6631411855941807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",14076,62,1.02 [0.79-1.33],0.8545575695113489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,13973,61,0.81 [0.52-1.26],0.340732972341161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,14074,62,0.97 [0.50-1.85],0.9199350582233758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,13994,60,0.87 [0.51-1.49],0.6228090362362735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,16689,73,1.58 [0.94-2.65],0.0863373687706155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,16497,71,0.83 [0.66-1.05],0.1268326411932175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,14386,64,0.96 [0.61-1.50],0.8532535896088778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,13973,61,0.36 [0.15-0.89],0.0277786911345355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,14413,64,1.03 [0.73-1.45],0.8594864597563918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16237,71,0.93 [0.49-1.78],0.8297078652284656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,14076,62,1.28 [0.56-2.97],0.5569450702142071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,14009,59,0.77 [0.39-1.52],0.4485272171078494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,14431,63,1.02 [0.79-1.33],0.8670346991172669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,14372,64,1.41 [0.73-2.75],0.306911003974726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,14178,64,0.75 [0.36-1.54],0.4286404895274506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16607,72,0.97 [0.49-1.90],0.922593392983226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,14413,64,1.25 [0.66-2.35],0.4879691400930888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,16529,72,2.01 [1.03-3.90],0.0395144395822487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16362,71,8.30 [5.84-11.80],4.3772634179296e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,14064,63,1.02 [0.66-1.58],0.927140116675772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,16512,70,0.84 [0.69-1.02],0.0834642263439602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,16187,69,0.35 [0.19-0.63],0.0005014748374677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,14372,64,1.30 [0.61-2.78],0.5043654869802316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,16740,73,1.86 [0.52-6.65],0.341833748195418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,16497,71,1.70 [1.43-2.03],4.0558436679352144e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,14431,63,0.91 [0.66-1.27],0.596652243578113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,14076,62,0.85 [0.69-1.04],0.1180099417508142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14421,64,1.06 [0.71-1.59],0.7790482773947733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14310,64,0.88 [0.70-1.11],0.2786600383562498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,13973,61,0.99 [0.68-1.45],0.9724981574776294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14076,62,1.08 [0.62-1.89],0.7842396275651501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,16390,71,1.03 [0.71-1.50],0.8704249834726591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,14009,59,1.04 [0.78-1.37],0.8074844662847235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16522,72,1.24 [0.91-1.68],0.1761676336268551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16703,73,0.99 [0.80-1.22],0.910964356977812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14413,64,0.83 [0.56-1.22],0.3410169000151198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,13973,61,0.77 [0.41-1.44],0.413080016736262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,16244,70,0.51 [0.23-1.11],0.0875639558682647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,14413,64,1.09 [0.82-1.45],0.5409475760681564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,13994,60,0.80 [0.57-1.11],0.1853049264969947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELN,Elastin,14431,63,1.07 [0.53-2.16],0.850216911044492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,16459,71,2.19 [1.92-2.51],3.843275936224265e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,13973,61,0.49 [0.22-1.07],0.0717491902096231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,16244,70,0.93 [0.59-1.47],0.7542956294564838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,13303,60,0.83 [0.52-1.32],0.4337189397706104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,16740,73,6.98 [2.98-16.39],7.942572497463508e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,16503,71,0.93 [0.71-1.21],0.5818421261193809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,16661,72,0.90 [0.65-1.25],0.5373628563720096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,14076,62,0.90 [0.58-1.40],0.6452769583850471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,14386,64,1.11 [0.75-1.63],0.6000202462323345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13973,61,2.95 [1.70-5.11],0.0001202948335795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,13973,61,0.83 [0.43-1.59],0.567668250056827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16740,73,3.53 [1.72-7.23],0.0005591125764734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16601,71,1.35 [0.78-2.34],0.278424856208706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14076,62,1.52 [0.77-3.02],0.2316660405727494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,15970,65,1.19 [0.91-1.55],0.1976805333257121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,14386,64,0.97 [0.61-1.54],0.8958260905241973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16187,69,0.93 [0.56-1.53],0.7729949085776042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16237,71,0.96 [0.36-2.53],0.9278699541090528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16237,71,3.02 [1.26-7.23],0.0128951353267498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,14076,62,1.77 [1.30-2.41],0.0002766562731635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,14009,59,0.97 [0.43-2.18],0.9376442791419256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,14064,63,0.75 [0.47-1.20],0.2358733400378818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,16517,71,0.83 [0.67-1.04],0.1062556877495224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,14386,64,0.70 [0.34-1.44],0.3357818892915911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,16584,71,0.83 [0.43-1.59],0.5674865205481738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,16155,71,1.24 [0.97-1.58],0.08363271183493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,15959,69,2.50 [1.56-4.01],0.0001528920855872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,14149,63,4.88 [2.16-11.01],0.0001336461305526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,16740,73,2.24 [1.04-4.82],0.0400171821558747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,16361,71,4.48 [2.57-7.80],1.197324268933928e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,16237,71,0.90 [0.62-1.29],0.557286219089838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,14178,64,0.71 [0.37-1.35],0.2943513040536725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16497,71,1.55 [1.26-1.90],2.4922406422957608e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,14076,62,0.95 [0.67-1.35],0.7822525878684118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16660,73,3.61 [2.09-6.22],3.884256729594903e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,16598,73,1.15 [0.47-2.77],0.7632914669928497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,16495,71,1.10 [0.37-3.22],0.8648859398163721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,16598,73,1.05 [0.44-2.52],0.9138203683921852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,16459,71,0.88 [0.72-1.08],0.2189571477908367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,14064,63,1.10 [0.83-1.47],0.4926554579993536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,13939,61,0.91 [0.43-1.94],0.8064146875265658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,16361,71,0.66 [0.49-0.89],0.0070880991420176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,14178,64,3.07 [2.05-4.60],4.957337917319399e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,14009,59,1.33 [0.76-2.33],0.3114095445832742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14386,64,0.78 [0.40-1.54],0.4744756041129951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,14149,63,0.91 [0.74-1.11],0.3478872990429552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,16427,71,0.97 [0.43-2.22],0.9466127021809754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,13973,61,0.66 [0.34-1.26],0.2045208403012319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,16740,73,1.26 [0.67-2.39],0.4761208203145296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,16522,71,1.32 [0.71-2.43],0.3815813127184878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,13939,61,1.07 [0.72-1.61],0.7302858133380908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,14009,59,1.09 [0.72-1.65],0.6820955887520674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,14421,64,0.95 [0.71-1.28],0.7268171463628481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,13939,61,1.20 [0.71-2.03],0.4906521327776932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,14009,59,1.01 [0.77-1.34],0.9252036528194372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,14178,64,0.98 [0.48-2.02],0.95775128003833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,13973,61,1.07 [0.71-1.62],0.7319283190834218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,13973,61,0.72 [0.39-1.33],0.2998773333673049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,16661,72,9.22 [6.47-13.14],1.1745742467077194e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,14451,64,1.10 [0.49-2.48],0.808405572398361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,14254,62,0.79 [0.33-1.87],0.5898100884806886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,16551,73,0.95 [0.65-1.38],0.782542992654175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,14460,64,1.06 [0.59-1.89],0.8532472690843961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,14383,62,0.71 [0.28-1.85],0.4892294307200032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,14460,64,1.39 [0.28-6.77],0.6859782718442167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,16576,71,0.74 [0.51-1.09],0.1288674533389324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,16590,73,1.31 [0.60-2.84],0.4964407995435898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,16609,72,0.81 [0.42-1.58],0.5374554520547528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,16597,72,0.64 [0.21-2.02],0.4514168808657623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",16522,71,0.94 [0.74-1.18],0.583397473770183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",16522,72,0.92 [0.70-1.20],0.5265549667533136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",14431,63,1.06 [0.66-1.70],0.808792623132438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",16740,73,1.12 [0.74-1.70],0.6030702645809876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,16601,72,0.93 [0.68-1.27],0.6400356898582574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,16207,71,0.84 [0.57-1.24],0.3822209366415489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,16497,71,1.00 [0.69-1.45],0.9859791744488896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,16522,72,0.91 [0.69-1.20],0.4961721659936947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,14372,64,0.83 [0.57-1.21],0.3310355529047381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,14413,64,0.97 [0.83-1.14],0.7328816640828163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,14386,64,1.22 [0.55-2.72],0.6268363636408583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,14076,62,0.86 [0.57-1.30],0.4686046798157978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,14431,63,0.88 [0.36-2.11],0.7699884490114336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,16459,71,1.43 [0.76-2.67],0.268645220794427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,16496,72,2.15 [1.11-4.18],0.0234783299972168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,14372,64,0.97 [0.74-1.28],0.8412611626561389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,16740,73,1.00 [0.46-2.15],0.995259726281706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,14064,63,0.83 [0.57-1.22],0.3513826683001525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,16702,73,1.50 [0.98-2.29],0.060450461338286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,16703,73,1.20 [0.68-2.13],0.5265961162924561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,14445,64,1.88 [0.90-3.95],0.0947517240228036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,14064,63,1.40 [0.96-2.05],0.082628068865042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",16522,72,0.85 [0.64-1.14],0.28717181792549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14431,63,1.74 [1.27-2.39],0.0005386188558974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,16497,71,0.74 [0.48-1.15],0.1830705874450826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14413,64,1.96 [0.78-4.97],0.154843931276141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,16551,73,7.32 [1.47-36.53],0.0152068690211675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16499,71,0.94 [0.67-1.31],0.7030771136983316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16187,69,1.66 [1.30-2.12],5.548705678599862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16583,72,1.03 [0.67-1.59],0.8789883514109255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,14421,62,0.74 [0.53-1.04],0.0846819384643224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,16487,71,0.84 [0.51-1.40],0.5115458445103136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16522,72,6.71 [5.58-8.06],5.2882841111893696e-92
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16619,73,5.71 [4.95-6.58],7.61825172199843e-127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16244,70,6.10 [5.04-7.38],1.643406809051568e-77
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,16551,73,5.30 [4.08-6.88],5.006465102749413e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,16497,71,1.11 [0.82-1.50],0.5168278240710056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,16187,69,1.43 [1.12-1.84],0.0043643328060735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",13973,61,1.01 [0.67-1.51],0.9744582119313698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",13973,61,0.90 [0.57-1.42],0.6497165773306954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,16187,69,1.53 [1.31-1.79],1.2117390699424992e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,16187,69,0.81 [0.50-1.32],0.3987699974359113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,16597,72,1.20 [0.61-2.34],0.5954678665822049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,14121,62,1.07 [0.48-2.40],0.8674814816447592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14413,64,1.00 [0.74-1.35],0.9762667608382658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,14009,59,0.71 [0.33-1.54],0.3877219626659685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,14009,59,1.04 [0.62-1.76],0.8780070370279469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,16601,71,1.00 [0.76-1.31],0.997355012160397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,16497,71,1.91 [1.47-2.49],1.4644063381916376e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,14009,59,0.61 [0.29-1.28],0.1872694946709024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,16659,73,0.99 [0.83-1.19],0.9513221089761132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,16665,73,1.36 [0.98-1.89],0.0631473714192584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,14009,59,1.20 [0.60-2.40],0.613328830135344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,16244,70,1.19 [0.63-2.24],0.594364793410212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,14009,59,0.55 [0.24-1.26],0.1575818246081176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,13939,61,0.63 [0.39-1.00],0.0483517795595395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,13917,61,1.02 [0.56-1.87],0.9421675770560156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16598,73,0.96 [0.51-1.83],0.9120356677708968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,14445,64,0.80 [0.50-1.31],0.3779488798383903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,14421,64,0.90 [0.47-1.74],0.7542346801635642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,16598,73,2.01 [0.80-5.05],0.1365037999273768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,14149,63,1.09 [0.68-1.73],0.7282842053106948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,14451,64,1.06 [0.73-1.53],0.7711448395876132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,16155,71,1.00 [0.70-1.42],0.9802713263236832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",13994,60,1.11 [0.85-1.43],0.4457624309201242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,13973,61,0.72 [0.40-1.29],0.2715418715562772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,16155,71,0.94 [0.71-1.26],0.6994778875775289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,16546,71,0.83 [0.62-1.11],0.2115837674673864
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14413,64,0.87 [0.69-1.11],0.2711548743631258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16568,73,0.93 [0.77-1.12],0.4232702812299309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16390,71,1.48 [0.90-2.42],0.1213340239353723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16390,71,0.95 [0.76-1.19],0.6474745409342468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16126,71,0.85 [0.52-1.40],0.5272183182914794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,14372,64,1.04 [0.69-1.57],0.8389154473059272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,16187,69,0.93 [0.77-1.14],0.5059411487356251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16390,71,2.40 [1.20-4.80],0.0136417617112403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,16423,71,1.84 [0.79-4.29],0.1582252042409575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,16187,69,1.35 [0.73-2.48],0.3379224213053805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,16703,73,1.57 [0.86-2.87],0.1423668703494804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,16598,73,0.71 [0.39-1.30],0.2733147802938923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,16155,71,1.26 [1.00-1.60],0.0518401077710779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,16187,69,1.28 [0.70-2.34],0.4210725976941101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,14460,64,0.67 [0.27-1.66],0.3819210580096548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,14421,64,0.72 [0.43-1.19],0.1942295239272369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14386,64,0.98 [0.49-1.99],0.963125203050566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,14009,59,0.98 [0.76-1.26],0.8593895693300654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,16528,73,1.68 [0.85-3.34],0.1388614781864804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,16661,72,1.35 [0.67-2.75],0.4044169166344936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,16546,73,0.99 [0.88-1.10],0.8203347159124768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,13917,61,1.30 [0.66-2.57],0.4446901257868282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,16155,71,0.84 [0.46-1.55],0.5832046833347111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,14009,59,1.61 [1.04-2.49],0.0311418467527654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,16497,71,1.35 [1.06-1.72],0.0154738895718444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,16187,69,1.00 [0.80-1.26],0.9804529337443798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,13973,61,0.92 [0.64-1.34],0.6748176887798514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,14064,63,0.72 [0.35-1.44],0.3500807312820084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,16335,71,1.77 [0.72-4.37],0.2144001228372579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,14076,62,1.30 [0.83-2.03],0.2577936861835931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FST,Follistatin,16576,71,0.87 [0.56-1.36],0.5505964734453364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,14076,62,1.33 [0.45-3.96],0.6089274763399175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,16494,71,1.71 [0.91-3.19],0.0955474117199987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,14391,64,0.92 [0.68-1.23],0.5572439019856952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,16652,72,0.84 [0.67-1.05],0.12634169599898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,14149,63,1.18 [0.81-1.74],0.3888945490786377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FURIN,Furin,16598,73,0.61 [0.32-1.16],0.1288984494472283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,16164,69,3.55 [2.74-4.60],1.006431537408304e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14143,64,1.14 [0.81-1.62],0.4556483466169104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16661,72,1.55 [1.00-2.38],0.048620430757366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",16390,71,0.83 [0.57-1.20],0.3269536766955873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",16689,73,0.91 [0.68-1.21],0.5121121531750354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,16244,70,0.85 [0.61-1.21],0.3704508951701922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,16516,73,0.97 [0.78-1.22],0.8232498079148058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,14064,63,0.65 [0.38-1.13],0.1270236808394678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,13994,60,1.02 [0.58-1.79],0.9473999361263106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,14386,64,1.00 [0.61-1.65],0.9929751409883272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14178,64,0.93 [0.63-1.37],0.7157472847098032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,13994,60,0.92 [0.60-1.41],0.6989745775493259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,13939,61,1.62 [0.63-4.19],0.3186987259517936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,14009,59,1.18 [0.73-1.90],0.4996210947607169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14178,64,0.60 [0.29-1.22],0.1582686463724777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14076,62,0.89 [0.55-1.44],0.6287298253419227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,13939,61,0.94 [0.64-1.39],0.7524308510305522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,16601,71,0.70 [0.50-0.97],0.0317654513437585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16459,71,1.00 [0.47-2.16],0.9946221157902454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16689,73,1.57 [0.73-3.40],0.2510953832098405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16244,70,2.70 [1.91-3.82],1.692163315268133e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14431,63,2.40 [1.28-4.50],0.0062240420381768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,16459,71,11.78 [4.43-31.31],7.70942079085737e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,13973,61,0.47 [0.18-1.21],0.1180457413562736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13825,59,0.72 [0.35-1.51],0.3839581599766309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,14413,64,1.01 [0.41-2.48],0.9767750339676604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,14178,64,0.61 [0.33-1.12],0.110103654541355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,16649,71,2.29 [0.99-5.29],0.0519637859483066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,13973,61,0.90 [0.50-1.61],0.7195606615448955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,14421,64,1.00 [0.85-1.19],0.9775637378422684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13939,61,1.11 [0.44-2.84],0.823611721188455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14076,62,1.10 [0.80-1.52],0.545987762776678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,14064,63,0.96 [0.61-1.50],0.8522709454313315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,14395,64,1.36 [0.97-1.91],0.0777666917037968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,16244,70,1.07 [0.75-1.52],0.7082462287913357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,16155,71,0.87 [0.55-1.36],0.5437142829677231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,13973,61,0.72 [0.37-1.42],0.3435714349032834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,14460,64,1.03 [0.41-2.59],0.9471298951833428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,14421,64,0.93 [0.74-1.15],0.4918703397500723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,16187,69,0.91 [0.77-1.08],0.2969252748424047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13812,57,1.69 [1.24-2.32],0.0010536380460606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,13973,61,1.08 [0.65-1.79],0.7553700360816518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16459,71,1.44 [0.79-2.61],0.232420433997767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,16740,73,1.52 [1.00-2.31],0.0507911491909448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,16522,72,0.43 [0.24-0.78],0.0056405236863215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,16155,71,1.09 [0.63-1.89],0.7487298140273873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,14431,63,0.88 [0.54-1.42],0.6046137659769695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,16155,69,0.90 [0.57-1.41],0.6416377522103114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,16187,69,1.23 [0.88-1.71],0.2265221094227612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16187,69,0.93 [0.76-1.13],0.4620336347084706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,16659,73,2.60 [1.35-5.00],0.0041985854327122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,16459,71,2.25 [0.89-5.67],0.0860813206948663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,16348,70,1.14 [0.54-2.41],0.7324064252181933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,13978,64,1.11 [0.75-1.62],0.6027321017350932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,16155,71,0.58 [0.37-0.91],0.018451019896595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,14431,63,1.00 [0.71-1.42],0.9815148995452492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,14398,63,1.18 [0.72-1.95],0.5064948597693633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,16300,71,1.12 [0.60-2.08],0.7300631640032169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,16529,72,0.85 [0.54-1.32],0.4642049339357293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,16390,71,2.38 [1.08-5.22],0.030534929248101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,16496,72,1.04 [0.92-1.17],0.516047713064445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,16187,69,0.66 [0.53-0.82],0.0001722222593252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,14149,63,1.15 [0.48-2.77],0.7511009983808472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,16155,71,0.77 [0.49-1.23],0.2782675267639135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,16522,72,0.92 [0.72-1.17],0.4987290210719438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,14413,64,0.82 [0.37-1.82],0.617305698651593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,14413,64,1.15 [0.84-1.57],0.3826473937084725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,14149,63,1.61 [0.89-2.89],0.1136639021598483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,13939,61,1.04 [0.65-1.67],0.869066577527177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,14076,62,1.10 [0.72-1.66],0.6648157233064882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,14421,64,2.09 [1.07-4.06],0.0299902497208822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,14372,64,0.90 [0.70-1.14],0.3747545146669698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,14009,59,0.74 [0.39-1.40],0.3588976035160305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,14009,59,1.07 [0.83-1.39],0.601699715246822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,13939,61,0.92 [0.61-1.40],0.6971215639193284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,15852,70,1.17 [0.54-2.54],0.685467498028443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,14125,63,0.56 [0.30-1.04],0.0679814834757212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,16390,71,1.02 [0.61-1.69],0.9473645924412002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,14009,59,1.13 [0.54-2.38],0.7455915059457633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,16237,71,1.08 [0.75-1.55],0.6708630471603971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,16521,71,1.23 [0.67-2.25],0.5112959789959315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,13994,60,1.46 [0.88-2.44],0.1464846355069439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,16404,72,1.18 [0.83-1.69],0.357699382989067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14149,63,0.89 [0.67-1.18],0.4188795923110406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16155,71,1.17 [0.80-1.72],0.4221008062496647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,14386,64,1.79 [1.41-2.26],1.6512512973330222e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,14082,59,1.56 [0.99-2.46],0.0535710647893166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,14431,63,0.91 [0.65-1.28],0.6069159273325766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,16703,73,1.37 [0.88-2.11],0.1594272246165066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,14149,63,0.97 [0.67-1.39],0.8586049179590497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,14413,64,0.68 [0.47-0.98],0.0403557018743528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16187,69,0.95 [0.68-1.32],0.7447715955072398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14064,63,1.18 [0.79-1.76],0.4122060002483994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,16551,73,1.52 [1.05-2.20],0.0263212952725054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,14076,62,1.07 [0.54-2.11],0.8473232671594153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,14149,63,1.18 [0.61-2.30],0.615759318171173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,14413,64,1.11 [0.82-1.50],0.5082197078526339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,16661,72,1.62 [0.74-3.55],0.2247940443969489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16497,71,0.92 [0.75-1.13],0.409912574936958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,14372,64,0.99 [0.60-1.65],0.9716453839339348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",14445,64,1.48 [0.90-2.43],0.1244611922363337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,16487,71,0.78 [0.41-1.50],0.4575515428089152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,13973,61,0.91 [0.63-1.31],0.6145454212472627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16044,69,0.96 [0.74-1.25],0.763686010849154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,14149,63,0.45 [0.24-0.82],0.0091663090597072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,16516,73,0.84 [0.66-1.06],0.1403434187505638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,16459,71,0.92 [0.79-1.08],0.3082020127249516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,16689,73,1.52 [0.75-3.06],0.2426192752240441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,16390,71,1.06 [0.73-1.55],0.7474814105160179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,14386,64,1.10 [0.70-1.74],0.686623780790054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,14372,64,0.71 [0.36-1.39],0.3193560999141605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,14451,64,0.86 [0.51-1.46],0.585853000565923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14372,64,1.48 [1.01-2.17],0.0440607609846838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,16155,71,2.04 [1.46-2.85],2.823099308658715e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,16077,71,1.54 [0.74-3.20],0.2510214578041144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,13994,60,0.62 [0.34-1.13],0.1187878403114894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,14413,64,1.38 [0.77-2.47],0.2862616617814429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,14372,64,0.62 [0.42-0.92],0.0188032022220431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,16237,71,1.06 [0.77-1.47],0.7200027398618668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,14386,64,0.89 [0.55-1.42],0.6194900118159703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,16522,72,0.94 [0.80-1.10],0.4157207676603449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14431,63,1.09 [0.74-1.60],0.671683505343398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",14413,64,1.08 [0.65-1.79],0.7649565055500064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",13994,60,1.04 [0.69-1.58],0.8353626795091794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,16237,71,1.26 [0.89-1.78],0.1941804805645161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16473,72,14.03 [8.11-24.28],3.711250841344263e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,14076,62,0.76 [0.49-1.18],0.2242122499110468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",16459,71,1.15 [0.81-1.64],0.4205742059591812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,13863,61,0.89 [0.65-1.22],0.4529335114263185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,16187,69,1.03 [0.81-1.31],0.8172196658436289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,14400,64,1.16 [0.33-4.15],0.8154195427029142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",14367,62,1.11 [0.36-3.38],0.8574679974277033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,16493,72,0.96 [0.75-1.25],0.7863623086019871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,16187,69,0.97 [0.72-1.29],0.8163386528398514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,13973,61,1.07 [0.78-1.46],0.660982310058897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,16059,71,1.08 [0.81-1.45],0.5963699822501647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,14421,64,0.99 [0.90-1.10],0.9072532983209838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14178,64,0.94 [0.65-1.36],0.7249293142971716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,14064,63,0.90 [0.66-1.22],0.4888692924745343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,16460,73,0.69 [0.37-1.27],0.2299240988663702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,14178,64,0.86 [0.60-1.21],0.3866765067478009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,13973,61,1.00 [0.53-1.88],0.998796952743378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,16637,73,0.84 [0.60-1.19],0.3307316038651537
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",16237,71,1.02 [0.81-1.28],0.8865193384542629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,16703,73,2.59 [1.70-3.94],8.791328957956138e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,16497,71,1.12 [0.83-1.51],0.4732743576492372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,16237,71,1.37 [1.14-1.64],0.0006055634475197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,13939,61,0.70 [0.36-1.36],0.2932326139729114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",13973,61,0.69 [0.41-1.18],0.1731010867911849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16631,73,1.19 [0.90-1.57],0.2330935070205715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,16689,73,0.98 [0.83-1.17],0.8452805730832803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",16551,73,0.96 [0.73-1.26],0.7781142987681893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,16661,73,0.90 [0.64-1.26],0.5416623316158151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16551,73,2.42 [1.45-4.03],0.0007151082933379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,16631,73,0.62 [0.46-0.82],0.0010543670281881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,16689,73,1.33 [0.98-1.80],0.072078808145162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,14431,63,1.02 [0.81-1.28],0.8641932504770987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,13973,61,0.95 [0.58-1.54],0.8271543916288852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,16703,73,1.38 [0.94-2.02],0.097578896578586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,14009,59,0.94 [0.60-1.48],0.8005219611023374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,13994,60,1.07 [0.76-1.51],0.7087841198993351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,14372,64,1.65 [1.01-2.70],0.0466856152494601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,16655,73,1.15 [0.92-1.43],0.2204473929720301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,14421,64,2.08 [1.63-2.65],4.054207110809133e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,16237,71,0.80 [0.52-1.24],0.3183987428198779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,14149,63,2.04 [0.82-5.05],0.1257104171075435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,14421,64,1.35 [0.77-2.38],0.2903072652449214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,14431,63,0.89 [0.38-2.07],0.78551330726662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,16497,71,1.02 [0.78-1.32],0.893757546072556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,16703,73,1.29 [0.71-2.35],0.4074013416493459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,14313,62,0.61 [0.37-1.01],0.0549198777586307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16187,69,0.82 [0.62-1.10],0.193839871153635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,14421,64,1.09 [0.79-1.49],0.6068200118715148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,14009,59,1.00 [0.67-1.51],0.9830663719370546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,13973,61,1.06 [0.52-2.16],0.865254906021277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,14385,64,1.16 [0.71-1.89],0.5590684188192118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,14413,64,0.95 [0.54-1.67],0.8490484418367183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,16237,71,0.93 [0.43-2.00],0.8577801464442476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",14413,64,2.56 [1.21-5.41],0.0143111328657957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16451,70,1.86 [1.10-3.16],0.021530496680602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16497,71,2.27 [1.25-4.12],0.0071453279196312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,16689,73,1.67 [1.02-2.74],0.0426443025982767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,14125,63,0.92 [0.60-1.40],0.6963080960491619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14076,62,0.85 [0.50-1.44],0.550463533769779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",13973,61,0.57 [0.30-1.10],0.0947203127728695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,13909,61,0.65 [0.35-1.21],0.1749235049763974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,16351,72,1.02 [0.66-1.57],0.9435014201122732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,16155,71,1.63 [1.19-2.22],0.0020395917022988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,14064,63,1.01 [0.71-1.42],0.9747807015909014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,16310,71,1.17 [0.75-1.83],0.4981740329385946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16192,70,1.16 [0.89-1.52],0.2829237450701291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14413,64,2.19 [1.77-2.72],1.0880226431846428e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,16703,73,0.87 [0.66-1.14],0.3148419555771085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,16187,69,1.00 [0.56-1.76],0.9908472386998456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,14249,60,0.84 [0.65-1.10],0.1999431774453722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,14142,64,0.81 [0.58-1.13],0.2150879471586463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14076,62,1.38 [0.72-2.67],0.3360988418866972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,14383,62,1.36 [0.64-2.90],0.4193536481363233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,14076,62,0.93 [0.70-1.23],0.5909838628006594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16459,71,0.68 [0.39-1.19],0.1762433229868449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16689,73,1.82 [1.25-2.64],0.0017220931725395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14009,59,1.70 [0.88-3.28],0.1132988198661337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,14076,62,0.91 [0.70-1.19],0.4876807129279816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16497,71,1.10 [0.65-1.88],0.7149509861340644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14421,64,0.95 [0.65-1.39],0.7892570089968479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,13973,61,0.91 [0.54-1.54],0.7287050721182715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14076,62,1.15 [0.70-1.90],0.5840456231522373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,16073,70,0.84 [0.57-1.24],0.3752883145606599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,16584,71,0.96 [0.71-1.29],0.7696367094839425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,14386,64,1.34 [0.71-2.53],0.3672005327366328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,16283,71,0.92 [0.69-1.25],0.6052254148235545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,16689,73,1.23 [0.73-2.07],0.4422090290575841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16444,71,1.47 [0.68-3.17],0.3217109455200753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,13994,60,0.80 [0.53-1.21],0.2948410517241604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,13994,60,0.92 [0.51-1.65],0.7713877606884192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",16598,73,0.97 [0.69-1.37],0.8823965143960781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,16474,71,0.58 [0.23-1.49],0.2595497903912521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,16740,73,2.77 [1.15-6.71],0.0235194277941409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,16244,70,0.89 [0.67-1.17],0.3919398766718536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16493,71,3.20 [1.73-5.92],0.0002067892480114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,16740,73,1.45 [0.76-2.76],0.2598169942623712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,16740,73,29.21 [19.18-44.50],1.2207907621428054e-55
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,16497,71,0.73 [0.49-1.08],0.1107259301747126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,16522,72,0.90 [0.57-1.41],0.634058539614647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,16459,71,9.26 [3.38-25.33],1.463058921376586e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,14178,64,1.10 [0.66-1.82],0.7233103617964217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,16155,71,0.84 [0.53-1.32],0.4450127303115683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",14076,62,1.04 [0.70-1.52],0.859209825280623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,16703,73,0.76 [0.08-7.52],0.8152656752492364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,16689,73,0.76 [0.50-1.17],0.2183322193237371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14007,64,3.24 [2.16-4.85],1.1424817640811614e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14178,64,0.81 [0.50-1.32],0.3904026076424586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14178,64,0.88 [0.46-1.70],0.7081657279737169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,14372,64,1.89 [0.88-4.06],0.1003228693014311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,16244,70,0.96 [0.79-1.16],0.6532134327115099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16601,71,3.14 [1.57-6.28],0.0012035152698653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,16390,71,0.80 [0.52-1.22],0.30351910415629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,16155,71,1.08 [0.68-1.72],0.7368018067617563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,13994,60,1.18 [0.84-1.66],0.3453241981900716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,16497,71,2.52 [1.96-3.25],9.527347404296058e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,13973,61,1.20 [0.68-2.12],0.5203179122853183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,14064,63,1.17 [0.68-1.99],0.5695522428091444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,14413,64,1.22 [0.83-1.80],0.3032791178243065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,13994,60,1.12 [0.71-1.76],0.63543128086588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14445,64,1.93 [0.80-4.66],0.1461065712762853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,16459,71,1.88 [0.77-4.59],0.1676391103426762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,13973,61,1.05 [0.63-1.76],0.8467866946109515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,16551,73,5.84 [2.58-13.23],2.281216119614115e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,16718,73,1.06 [0.90-1.26],0.4794687915157579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,16717,72,1.27 [0.89-1.80],0.1820132379876622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,16627,72,0.76 [0.41-1.42],0.3940944806198229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,16353,73,1.35 [0.87-2.10],0.1847736997484172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,16485,71,1.46 [0.76-2.79],0.2575986400545346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,16740,73,1.65 [0.94-2.90],0.0821524822865991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,16522,72,1.50 [0.83-2.71],0.1830930542783306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,14009,59,0.75 [0.47-1.21],0.2403090836150345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,13973,61,0.86 [0.54-1.38],0.5394526895417733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,14430,64,0.44 [0.12-1.61],0.2163775361717294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,13939,61,0.94 [0.70-1.26],0.6752797563670221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,14076,62,0.74 [0.37-1.49],0.4006143519758632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,16459,71,9.45 [7.50-11.90],8.19939543869659e-81
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,16522,72,1.43 [0.76-2.69],0.2690901373883609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,14431,63,0.92 [0.69-1.24],0.5988591659649886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,16497,71,1.09 [0.86-1.38],0.456651000581007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,16187,69,1.05 [0.84-1.32],0.6661769900814325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16244,70,1.41 [1.19-1.68],8.650215997399026e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,16244,70,0.94 [0.64-1.39],0.7673921995071342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,16601,71,2.15 [1.33-3.46],0.0016775477781385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,16244,70,0.86 [0.59-1.25],0.4272335946956745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16459,71,1.70 [1.35-2.15],7.161644558855619e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16703,73,2.01 [1.40-2.88],0.0001494546592052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,16244,70,2.71 [1.74-4.23],1.0987506655420892e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,14009,59,2.26 [1.44-3.55],0.0003762978440844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,16244,70,0.71 [0.39-1.28],0.2513224533172935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,16349,73,1.76 [0.72-4.32],0.2175651806763589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,13994,60,1.05 [0.45-2.49],0.9031313729682444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,16497,71,0.54 [0.28-1.04],0.0647354205330329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,16244,70,2.27 [1.26-4.08],0.0065450830944878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,16703,73,2.41 [1.82-3.19],6.30358606416451e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,16223,70,0.66 [0.37-1.18],0.1613018805721934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,16244,70,1.16 [0.89-1.51],0.272176133518264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,16244,70,1.15 [0.66-1.99],0.6217765649216254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,16244,70,0.91 [0.66-1.24],0.5457588423136075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,16551,73,1.22 [0.76-1.94],0.4120234667080431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,16296,70,1.20 [0.81-1.79],0.3583084379563183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,16474,70,1.29 [0.83-2.01],0.2626849295731954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16627,72,3.80 [2.27-6.38],4.207871327652296e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,16703,73,1.13 [0.60-2.12],0.6991061104696352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,16286,71,0.88 [0.77-1.01],0.076328824163736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,16102,71,0.90 [0.66-1.23],0.5140956158422862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,16244,70,0.85 [0.57-1.28],0.4409335415132084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,16174,69,1.10 [0.76-1.57],0.6175346841639104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,16529,72,1.86 [0.77-4.45],0.1651540430121733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,16504,71,0.63 [0.22-1.79],0.3878239262893846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,16551,73,1.17 [0.75-1.83],0.4865857980369578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,16702,73,1.02 [0.64-1.61],0.939962394665302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,16244,70,1.34 [0.76-2.37],0.3181598187946142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,16513,71,1.26 [0.88-1.79],0.2074194218401304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,16244,70,1.84 [0.98-3.45],0.0571547428602544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,16244,70,1.26 [0.91-1.75],0.1694449766877291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,16244,70,0.71 [0.39-1.28],0.2530331992280807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,14009,59,1.56 [0.91-2.69],0.1053927360728518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,14009,59,0.49 [0.24-1.00],0.0501852503498879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,14386,64,0.74 [0.51-1.09],0.1314973426572899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,16244,70,0.67 [0.37-1.20],0.1781134660415044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,16244,70,1.00 [0.65-1.52],0.9890233360729344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,13887,61,1.21 [0.59-2.49],0.6025215094996503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16414,71,5.16 [3.56-7.48],4.0250707870243294e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,16244,70,0.99 [0.56-1.74],0.9791405116498428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,14386,64,1.77 [1.22-2.56],0.002664498628827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,13939,61,1.04 [0.70-1.56],0.8453310025382259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,14009,59,0.67 [0.37-1.19],0.1714357796928446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,13948,59,1.35 [0.70-2.62],0.3674090459321355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,16497,71,1.22 [0.77-1.95],0.3988126207559526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,16244,70,0.93 [0.54-1.60],0.7920230691328587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,16132,71,0.86 [0.49-1.53],0.6129926305633273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,14009,59,0.84 [0.50-1.40],0.5001971047324718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,13945,57,0.60 [0.37-0.98],0.0427636755680684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,16244,70,1.26 [0.66-2.42],0.4869367132569551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,16244,70,0.84 [0.71-1.00],0.0468635228331835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16497,71,3.81 [2.75-5.29],1.2132127539253113e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,16244,70,0.80 [0.67-0.96],0.017765360307304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,16497,71,0.47 [0.31-0.69],0.0001549530305516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,16459,71,1.16 [0.90-1.49],0.2394968978903186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,16471,71,1.10 [0.60-2.03],0.7624089671894237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,16522,72,0.89 [0.26-3.00],0.8527587564937769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,16497,71,0.49 [0.35-0.70],7.62750924297995e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,16551,73,0.92 [0.62-1.37],0.6940126092635543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,14178,64,0.97 [0.62-1.51],0.8979469769945081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16133,70,1.59 [1.22-2.07],0.0005318486958205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,14386,64,1.13 [0.67-1.90],0.6547018799998032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,16390,71,0.87 [0.61-1.24],0.4462511395113731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,14421,64,1.21 [0.79-1.86],0.3864060981525279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,13994,60,0.71 [0.29-1.76],0.4625482016944242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,16126,71,2.05 [1.70-2.47],2.89025278869809e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,14149,63,1.14 [0.72-1.81],0.5692852940186905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,16551,73,0.94 [0.56-1.57],0.8010464848646427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,16459,71,0.95 [0.64-1.42],0.8087256327334547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14076,62,2.43 [1.69-3.51],2.008403177507879e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14413,64,1.04 [0.60-1.82],0.8857082843768755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16459,71,0.91 [0.73-1.13],0.3878109874153648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,14421,64,0.91 [0.69-1.20],0.5051640040204654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,14386,64,0.84 [0.49-1.46],0.547461367894476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,14372,64,0.88 [0.68-1.14],0.3344502199725883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,14009,59,5.55 [1.49-20.62],0.0105783028673677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,16362,71,1.04 [0.82-1.31],0.7696059729485253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,16459,71,0.79 [0.53-1.19],0.2546956969543328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16237,71,1.41 [1.16-1.70],0.0005026027189664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,16244,70,0.96 [0.70-1.32],0.8027012883730646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,16497,71,0.96 [0.79-1.18],0.7025671589633478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15938,70,0.92 [0.52-1.62],0.7685245666270117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,16497,71,1.36 [0.80-2.30],0.2599101064168129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,14445,64,0.97 [0.55-1.71],0.9164874848320328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,14257,64,0.96 [0.75-1.22],0.7132756261926003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,16497,71,0.76 [0.41-1.41],0.3842888002842137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,14149,63,0.85 [0.42-1.73],0.6587402329887958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,16551,73,1.80 [0.79-4.11],0.1600928321701161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,16497,71,0.52 [0.32-0.84],0.0071084547755654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,14009,59,3.36 [1.82-6.19],0.0001036170461392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,16551,73,0.61 [0.31-1.19],0.1455516682694713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,16689,73,0.50 [0.14-1.71],0.2672734827117244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,14178,64,0.77 [0.47-1.23],0.2737687335437806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,16556,72,1.35 [0.51-3.54],0.5469785850696365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,16187,69,0.68 [0.41-1.14],0.1453081303280475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,16237,71,0.97 [0.80-1.17],0.732659520034249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,16453,72,1.55 [0.75-3.21],0.2392457576606007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,16598,73,0.77 [0.43-1.37],0.3750896002831386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,16244,70,1.17 [0.59-2.35],0.6509331899476016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,16689,73,1.22 [0.79-1.89],0.3624987983068163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,14445,64,1.83 [1.05-3.17],0.0323871959225355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14460,64,0.69 [0.19-2.48],0.5679491997439301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16627,72,1.57 [0.89-2.76],0.1155015648313396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14460,64,0.75 [0.28-2.02],0.5665769270958521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14386,64,0.71 [0.39-1.30],0.270315634712401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,16497,71,1.25 [0.89-1.75],0.2034399512743991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,13973,61,1.15 [0.80-1.67],0.447315032967253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14076,62,0.60 [0.38-0.93],0.0222650570694774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",13994,60,0.63 [0.32-1.28],0.2017790950598369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16155,71,0.97 [0.64-1.47],0.8798639486551435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,13939,61,0.99 [0.58-1.70],0.9670494911086964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,16661,72,2.06 [1.01-4.21],0.0477524210913636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,14149,63,0.86 [0.52-1.43],0.5621638160903215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,16244,70,0.70 [0.50-0.99],0.0423788612126651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13939,61,0.83 [0.51-1.33],0.4317026462130903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,14372,64,0.99 [0.75-1.31],0.9556491071009175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,16244,70,1.40 [1.03-1.89],0.0307899488527282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16459,71,1.75 [1.06-2.89],0.0293047488493206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,14372,64,0.97 [0.77-1.22],0.7974144894589765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,13994,60,0.34 [0.16-0.71],0.0041389274283667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,14064,63,0.37 [0.20-0.69],0.0018294560209866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,16155,71,0.98 [0.64-1.50],0.9262560077529614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14158,62,2.25 [1.70-2.99],1.7948711735384983e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,14009,59,0.94 [0.69-1.28],0.6890657230044928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,16598,73,1.09 [0.48-2.51],0.835141759640074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,16155,71,2.26 [1.28-4.01],0.0050137641923674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,13939,61,0.90 [0.60-1.35],0.595054377342048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,14076,62,0.85 [0.57-1.27],0.4275419133195406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,14421,64,2.14 [1.32-3.45],0.001887711530398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,14178,64,0.96 [0.68-1.34],0.7962081061943206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,14178,64,1.02 [0.44-2.36],0.9710212951296266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,14386,64,0.98 [0.62-1.54],0.9306823532513128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,13973,61,1.11 [0.55-2.24],0.7694443898953748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,13994,60,1.19 [0.91-1.56],0.2107970964517295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,13973,61,1.30 [1.05-1.61],0.0181037090714784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,16459,71,0.96 [0.75-1.24],0.7709111075720817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14386,64,1.29 [1.00-1.68],0.0519669990595262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16187,69,1.32 [1.02-1.71],0.0340385139820802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14372,64,0.96 [0.84-1.11],0.6023290355340296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16187,69,0.94 [0.80-1.12],0.5087712586063369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13939,61,0.88 [0.62-1.24],0.4640395485090792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,13994,60,1.00 [0.65-1.54],0.9899491372235352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,16155,71,0.89 [0.52-1.52],0.665226173984813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,16597,72,0.86 [0.43-1.74],0.6788471594149579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,16522,72,1.39 [0.78-2.48],0.2706324027009069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,16155,71,0.96 [0.73-1.28],0.7977236377764186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,13994,60,1.61 [1.05-2.45],0.0280717081895806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,14413,64,0.98 [0.59-1.63],0.937795080886286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,16376,72,1.07 [0.91-1.25],0.410141926308465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,16546,73,0.47 [0.27-0.80],0.0059802639433935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,16440,73,1.36 [0.80-2.32],0.2591209960638918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,16187,69,0.93 [0.80-1.09],0.382891864426235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,16176,70,0.71 [0.44-1.14],0.1511678399232175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,16689,73,0.76 [0.49-1.20],0.2359809893878777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,14363,64,1.44 [0.92-2.25],0.1119612434529019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,14445,64,0.94 [0.74-1.20],0.6323197326347642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,16689,73,1.30 [0.96-1.76],0.093288667088383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,16569,73,1.31 [0.67-2.55],0.433064756585971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,13790,59,0.53 [0.27-1.06],0.0720212339698852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,16004,72,1.01 [0.56-1.80],0.982393483287558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,14147,62,0.87 [0.32-2.35],0.7784646980294324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,16703,73,2.11 [1.27-3.49],0.0036558883242106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,13994,60,0.92 [0.58-1.44],0.7073058584713219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,16703,73,1.05 [0.68-1.63],0.8222153695764687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,14009,59,1.51 [1.08-2.13],0.0173199835688755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,14421,64,1.77 [1.24-2.53],0.001703266282012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",15634,70,0.65 [0.29-1.49],0.3140400397345095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",13973,61,1.40 [0.89-2.19],0.1428806650135012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",16459,71,1.03 [0.79-1.33],0.8401123153266891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",16462,71,1.06 [0.77-1.44],0.7347122099921028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",16155,71,0.77 [0.50-1.20],0.2448101492738068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",13973,61,0.70 [0.32-1.52],0.3645463877867133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",13994,60,1.12 [0.87-1.45],0.3900064524032799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,16502,72,1.32 [0.93-1.88],0.1165207353074064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,16703,73,1.30 [0.83-2.04],0.2587841326005027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,16598,73,8.22 [4.63-14.61],6.858367080501837e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14431,63,0.95 [0.73-1.25],0.7303162478094025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,14352,64,1.00 [0.61-1.64],0.9916343081776772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,16522,72,0.96 [0.70-1.33],0.8242708785985008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16459,71,2.84 [1.98-4.08],1.6118157362222784e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16522,71,1.90 [1.21-2.98],0.0052414490912477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16390,71,1.00 [0.82-1.22],0.9826684433879794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,13973,61,0.84 [0.48-1.46],0.5408303504010269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,16601,71,0.59 [0.31-1.14],0.1172598747987862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,14076,62,0.98 [0.43-2.20],0.9563688247842672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,14035,60,0.49 [0.15-1.57],0.2276812791201226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,16025,67,0.73 [0.25-2.13],0.5676534951626995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,16678,73,1.30 [0.88-1.93],0.1931258037794242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,14386,64,0.66 [0.34-1.27],0.2123588585365647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,16244,70,0.94 [0.59-1.48],0.7772871345695035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,14386,64,1.15 [0.81-1.64],0.4287566206107684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,16703,73,0.82 [0.63-1.06],0.1280913332959729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,16459,71,0.93 [0.78-1.10],0.4006418268440452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,14009,59,0.94 [0.69-1.27],0.6692207471439084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,16361,71,2.28 [1.37-3.78],0.0014828026207553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,16627,72,1.15 [0.80-1.64],0.4440748541536701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,16661,72,1.15 [0.88-1.52],0.3080112576512134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,14451,64,0.55 [0.23-1.30],0.172203704426998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,14413,64,1.20 [0.85-1.68],0.3033628520033611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,16086,71,0.75 [0.43-1.34],0.3356621902751995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,14445,64,1.10 [0.67-1.81],0.7154372003276287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,16585,73,0.90 [0.59-1.36],0.6132929084583318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,14413,64,0.85 [0.66-1.09],0.1931494931074672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,14431,63,0.50 [0.35-0.73],0.0003065205269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,16659,73,0.64 [0.42-0.95],0.028793589814118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,13687,59,0.81 [0.56-1.19],0.2898799857270318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,13994,60,0.98 [0.69-1.40],0.9242739391440424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,14413,64,1.29 [0.76-2.20],0.3483534189515519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,16522,72,0.73 [0.54-0.99],0.044305030038175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,16522,72,1.04 [0.54-2.02],0.8988668915217831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,14413,64,1.16 [0.76-1.78],0.4988904326061889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,16522,72,1.44 [0.80-2.57],0.2231162018954918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,16586,71,1.23 [0.61-2.50],0.5637627962406637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,14460,64,1.15 [0.54-2.45],0.7255713252961642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,16522,71,0.86 [0.58-1.27],0.4475758663471386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,16501,71,0.71 [0.42-1.21],0.2071018850675643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,16661,72,1.05 [0.74-1.48],0.7882090964631893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,16538,71,1.79 [0.94-3.42],0.0762880754291919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,16601,71,0.54 [0.29-0.99],0.0455490062793223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,16187,69,1.08 [0.86-1.35],0.5121660200653515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16551,71,1.35 [0.97-1.88],0.0708206595710884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,16155,71,1.00 [0.67-1.51],0.9911639250852048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,16497,71,1.41 [0.58-3.38],0.4474794370218203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16551,73,1.23 [0.68-2.23],0.4916824942102351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14445,64,0.96 [0.83-1.13],0.6495971363186348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,13973,61,0.86 [0.50-1.48],0.588087216430137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16496,72,0.91 [0.47-1.75],0.7788102141061823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14431,63,0.84 [0.61-1.16],0.2943783820129966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16740,73,9.19 [4.66-18.11],1.5022416098746172e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16679,72,2.07 [1.09-3.92],0.0263475866535715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16244,70,1.72 [1.10-2.68],0.0175270802512793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16740,73,1.28 [0.93-1.76],0.1289197641623631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,14076,62,0.95 [0.64-1.40],0.7800890275591973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,14347,64,1.36 [1.01-1.84],0.0414661902511498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,14421,64,2.31 [1.17-4.55],0.0160243523229692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,14413,64,1.38 [0.75-2.54],0.3038936301974808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,13994,60,0.69 [0.43-1.11],0.1255233176188017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",14076,62,0.96 [0.72-1.29],0.791528187061225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),14127,62,1.06 [0.93-1.22],0.3774536037598041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,16459,71,1.14 [0.75-1.73],0.539352302117549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,16522,72,1.05 [0.67-1.64],0.8206545114963489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,15963,70,0.91 [0.64-1.30],0.6044381515803983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,13973,61,0.84 [0.57-1.24],0.374114101093063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13973,61,1.51 [1.11-2.06],0.0083226072119687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14064,63,0.67 [0.35-1.31],0.2470518420343065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,14460,64,3.44 [1.50-7.92],0.0036411662958554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16631,73,1.25 [0.69-2.25],0.4579788523734901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13957,59,1.41 [0.67-2.96],0.3642324748453518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,16459,71,1.32 [0.61-2.84],0.4855427011946808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,16522,72,1.81 [1.04-3.12],0.0343659988568848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,14064,63,0.74 [0.36-1.53],0.4159566031459392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,14064,63,1.06 [0.81-1.39],0.6475745508244356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16661,72,0.67 [0.41-1.08],0.0963761564504683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,16459,71,1.43 [0.87-2.35],0.1539559575595441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,14372,64,5.06 [2.98-8.57],1.8341843219947638e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,14064,63,0.95 [0.57-1.58],0.8399076540858486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,14431,63,0.99 [0.60-1.65],0.9774438468501928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14386,64,1.05 [0.64-1.71],0.8600404490847933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,16244,70,1.38 [0.80-2.39],0.2485009293629708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14064,63,1.23 [0.74-2.06],0.4216544150208022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14413,64,1.99 [0.96-4.11],0.0630190085912942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,16187,69,0.53 [0.32-0.87],0.0125414831834635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,14178,64,0.97 [0.72-1.30],0.828072836981993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,16497,71,5.28 [3.72-7.50],1.5540175900655262e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16497,71,2.99 [2.49-3.58],5.845290395144054e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,16689,73,0.99 [0.69-1.42],0.9665961554801292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,14386,64,1.57 [1.02-2.41],0.0392416785473538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,16740,73,1.78 [0.94-3.36],0.0770004350836776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,16187,69,1.38 [1.00-1.91],0.0484115857850302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,16467,71,1.91 [0.99-3.69],0.0539222750369172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,16244,70,1.01 [0.60-1.70],0.9631812684305524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,14386,64,1.38 [0.89-2.14],0.1469611017666265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LXN,Latexin,16321,71,1.28 [0.97-1.68],0.0836872451844806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,16474,70,0.91 [0.52-1.61],0.7492730996673262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,16497,71,4.58 [2.52-8.30],5.499644623914551e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16324,73,26.43 [18.21-38.36],1.5552923029240036e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,16390,71,0.35 [0.19-0.66],0.0010998295517806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,16187,69,1.67 [1.42-1.96],2.8374805793825405e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,16459,71,0.96 [0.75-1.22],0.7208208524826863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,16155,71,0.40 [0.21-0.77],0.005444850026495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,16456,73,1.73 [0.99-3.02],0.0546564681755016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,16187,69,1.49 [1.14-1.96],0.0036454134006084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,13994,60,0.94 [0.74-1.21],0.6427343794457681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14064,63,0.93 [0.72-1.19],0.5422387350091198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14460,64,1.07 [0.32-3.62],0.9075472735991084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,13939,61,0.70 [0.33-1.48],0.3525352139776931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,14149,63,1.00 [0.71-1.41],0.9925251496387056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,14076,62,1.22 [0.72-2.09],0.4575867172042032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16327,71,1.76 [1.43-2.17],9.69554428776978e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,16187,69,1.12 [0.66-1.93],0.6696602717733686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,14064,63,1.19 [0.73-1.93],0.4901255946781179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,14178,64,0.84 [0.66-1.06],0.1405134908300625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,16187,69,1.43 [0.98-2.09],0.0622959963529662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,14431,63,1.52 [0.79-2.95],0.2106200828958609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,14386,64,1.13 [0.73-1.74],0.5796644879574393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14076,62,6.95 [2.70-17.90],5.841893973744489e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,14431,63,0.89 [0.60-1.33],0.5791185317214332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13939,61,0.93 [0.57-1.54],0.7903295655354203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,16601,71,0.89 [0.76-1.05],0.1799908269693663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,16598,73,0.65 [0.30-1.40],0.2669254756232369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,13973,61,1.28 [0.93-1.77],0.1350564063972386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,13994,60,0.95 [0.43-2.10],0.9080793870900667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,13973,61,0.61 [0.33-1.12],0.1074516329884004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,14421,64,2.45 [1.84-3.28],1.2627469911250482e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14372,64,1.12 [0.77-1.64],0.5484248246520824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16497,71,0.93 [0.76-1.15],0.5323566636135473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16187,69,1.06 [0.86-1.32],0.5796088019097702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16361,71,0.95 [0.79-1.15],0.6126793280557263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,13939,61,1.79 [1.30-2.45],0.0003162321405889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,16497,71,0.91 [0.55-1.49],0.6965768805422967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,14178,64,1.01 [0.73-1.41],0.9377848199620252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,13939,61,0.98 [0.83-1.17],0.8567497676683395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,16155,71,0.87 [0.60-1.29],0.4960538497868583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,16522,72,3.29 [1.51-7.18],0.0027128375646246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",14125,63,0.97 [0.73-1.30],0.8509250564812494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,16361,71,0.56 [0.23-1.39],0.2102108131667747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,16550,71,1.04 [0.50-2.16],0.9084870936287408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,16362,71,0.52 [0.27-1.01],0.0528088938884143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,16187,69,0.92 [0.72-1.17],0.4806381274232798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAX,Protein max,16155,71,0.91 [0.75-1.12],0.3749900530594374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,16740,73,1.10 [0.76-1.61],0.607256782349263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,14256,62,0.92 [0.74-1.15],0.4531209371948831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,16627,72,2.34 [1.36-4.02],0.0021521938279201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14413,64,0.73 [0.38-1.38],0.331749534060645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,14009,59,0.93 [0.70-1.24],0.6240835703099257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,16436,72,0.86 [0.53-1.39],0.5381829800087546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,14372,64,1.12 [0.49-2.56],0.7917173625211806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16390,71,0.88 [0.65-1.18],0.3861200058399744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",14369,62,1.25 [0.70-2.25],0.447984563014954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDK,Midkine,16556,73,0.71 [0.46-1.10],0.1234264334839045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,14064,63,0.62 [0.27-1.40],0.2525532711344387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14076,62,1.02 [0.78-1.33],0.904834189259768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,16187,69,0.86 [0.64-1.14],0.2799615708054584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,13973,61,0.97 [0.58-1.62],0.902168546734316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,16522,71,0.97 [0.56-1.67],0.9080133695112168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,13973,61,1.39 [0.79-2.47],0.2536227623638118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,16702,73,1.35 [0.45-4.02],0.5877075030075855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,14431,63,0.84 [0.37-1.88],0.6656180050094982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,14149,63,0.77 [0.27-2.19],0.6291294435088763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,14372,64,0.85 [0.60-1.19],0.3303427662895372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,16522,72,0.99 [0.83-1.19],0.949920638090559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,16522,71,1.49 [0.62-3.61],0.3748607357003594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,16703,73,1.26 [0.55-2.88],0.5787813658200542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,16551,73,0.92 [0.77-1.09],0.3191169843894848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,16586,72,1.50 [0.52-4.31],0.4512606658735857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,16155,71,0.80 [0.38-1.69],0.5557218015642167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16497,71,0.87 [0.67-1.13],0.3099999879824676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,16659,73,1.16 [0.80-1.69],0.4227854326286999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,16237,71,0.96 [0.61-1.51],0.8629228857639981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,14064,63,0.86 [0.57-1.31],0.4917816016617354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,14149,63,1.63 [0.77-3.43],0.2025220589461012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,16740,73,1.10 [0.65-1.84],0.7274366946183184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,16551,73,0.80 [0.49-1.31],0.3817196615488801
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,16576,71,0.82 [0.65-1.03],0.0943163761868044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,16497,71,1.00 [0.84-1.19],0.9913586137924514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,16598,73,1.10 [0.63-1.92],0.7454260428746964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,14064,63,0.93 [0.64-1.35],0.7099384261599915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16497,71,1.03 [0.89-1.19],0.7166052542720854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,16529,73,1.11 [0.82-1.52],0.4950325860114556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,16244,70,1.62 [1.10-2.40],0.0155156548566871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14386,64,0.94 [0.75-1.17],0.5741526128154497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,14421,64,0.92 [0.71-1.19],0.5283578068408183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,16390,71,0.93 [0.75-1.16],0.5324441430861088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,14009,59,1.07 [0.58-1.97],0.8194841006220503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,13939,61,1.12 [0.79-1.57],0.523618791344199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,16497,71,0.91 [0.72-1.16],0.4426566653802241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,16459,71,0.95 [0.72-1.24],0.6987193033590879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,15921,69,0.96 [0.76-1.22],0.7527174204214918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,16489,69,0.82 [0.56-1.20],0.3009196262875593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,16555,73,0.96 [0.65-1.42],0.856464146799107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,16155,71,0.54 [0.28-1.03],0.060090225903824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,14431,63,1.19 [0.80-1.77],0.3971670767240451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,16551,73,1.33 [0.89-1.98],0.1659032618592029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,16211,71,1.04 [0.67-1.61],0.8649566426342851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,16629,72,1.16 [0.88-1.54],0.292603247933172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,16521,71,1.29 [0.90-1.83],0.1610523606915116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",13973,61,0.87 [0.52-1.47],0.6128549527741642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,14064,63,0.70 [0.42-1.15],0.1582764624119506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,14178,64,1.36 [0.89-2.09],0.1588364091771403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,16493,72,1.03 [0.84-1.26],0.7626217800939032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,14149,63,1.07 [0.73-1.55],0.7387172983052307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,16689,73,1.63 [0.89-3.00],0.1131152212728742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,14421,64,2.64 [1.78-3.93],1.6564707266287776e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,14178,64,1.38 [0.88-2.15],0.1602596940174027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,13939,61,1.64 [1.02-2.65],0.0430619294978283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,13939,61,1.19 [0.92-1.54],0.1805858806652944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,16237,71,1.11 [0.84-1.46],0.4673961697067532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,16459,71,1.04 [0.81-1.34],0.735977486010721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16576,71,0.83 [0.64-1.07],0.1519750906048178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,16551,73,1.01 [0.64-1.57],0.9823358462429982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,14351,64,0.73 [0.41-1.28],0.2694468934514085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,14451,64,2.36 [1.07-5.18],0.0323608524283331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,14064,63,1.15 [0.80-1.67],0.4456709164658995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",13973,61,0.62 [0.29-1.34],0.227751277731241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",14413,64,0.68 [0.29-1.64],0.3931167734608215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",16155,71,0.91 [0.42-1.98],0.8054270182905974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",13909,61,0.97 [0.39-2.44],0.94802737526883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14413,64,0.66 [0.42-1.01],0.0573322636314075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",14009,59,0.97 [0.40-2.33],0.9396558032417348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,16429,71,1.27 [0.91-1.80],0.1646505097766709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,14064,63,0.98 [0.52-1.87],0.9571927625081676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,16501,69,1.06 [0.79-1.44],0.690453583178052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,16661,72,1.31 [0.82-2.08],0.2527135058520155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,16598,73,0.84 [0.63-1.13],0.2525505676333047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,14216,62,0.92 [0.67-1.24],0.5724159911753048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,16237,71,1.06 [0.71-1.58],0.7859422685109315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,14009,59,1.19 [0.92-1.55],0.1897494659526307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14421,64,0.86 [0.32-2.29],0.7582791375980553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14178,64,1.03 [0.83-1.28],0.7606209473076719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",14372,64,0.86 [0.65-1.14],0.2949033030879946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,16237,71,0.91 [0.46-1.79],0.7851642751042113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,13973,61,1.19 [0.88-1.60],0.2531539894955036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,14372,64,1.11 [0.90-1.38],0.3286471284591349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,14386,64,0.91 [0.71-1.16],0.4255471558086841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,14178,64,0.95 [0.61-1.48],0.8184400583003232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,16155,71,1.18 [0.78-1.78],0.4351549879789667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,16459,71,1.02 [0.91-1.13],0.7902516837443532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,14445,64,0.92 [0.71-1.19],0.5187465321863882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,13939,61,1.02 [0.58-1.80],0.9354250721713608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,16244,70,0.99 [0.76-1.30],0.952894007295054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,14149,63,1.20 [0.54-2.64],0.6543085965979819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",14431,63,1.05 [0.75-1.46],0.7823638167462185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",14076,62,1.16 [0.91-1.49],0.2284477839527747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14413,64,1.51 [1.14-1.99],0.0035892632748519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,14431,63,0.92 [0.71-1.18],0.4901431658063764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,13973,61,0.57 [0.28-1.14],0.1108353684155082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,13939,61,0.51 [0.24-1.06],0.0723627873405383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,14445,64,1.08 [0.88-1.33],0.4533265762239414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",13973,61,1.24 [0.71-2.15],0.4472048854128553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,14076,62,1.05 [0.75-1.46],0.7965178252250673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,14076,62,1.46 [1.02-2.10],0.0402455972230624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,14064,63,1.02 [0.78-1.32],0.9056515398871195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14064,63,0.77 [0.44-1.37],0.3786091707577953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,14413,64,0.96 [0.49-1.87],0.90296788805973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,16244,70,0.98 [0.71-1.36],0.9125004982301788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,16551,73,0.84 [0.53-1.33],0.4556102668827861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,13994,60,0.43 [0.20-0.90],0.0254755413743575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,13973,61,0.76 [0.44-1.30],0.3121217821451188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,14149,63,0.99 [0.76-1.29],0.9315567229457006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,16575,71,0.51 [0.34-0.77],0.0012655694064247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,16187,69,0.83 [0.53-1.31],0.4312405218520244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,13973,61,0.81 [0.49-1.32],0.3907751861745975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,14064,63,0.91 [0.74-1.12],0.3703249565575689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,16315,71,1.04 [0.73-1.48],0.8354568499922528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,14386,64,1.47 [1.03-2.09],0.0345367389845837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,16522,72,1.00 [0.68-1.45],0.983924199204144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,13977,59,0.88 [0.54-1.44],0.6067349396824586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,14049,62,1.52 [1.00-2.30],0.0487220085603228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14149,63,6.08 [2.78-13.29],5.937504471117749e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,16187,69,0.82 [0.52-1.30],0.4085261240299827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,14342,64,1.77 [0.96-3.28],0.0681362598577228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,14421,64,1.31 [0.69-2.49],0.4065670491220706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",14413,64,1.20 [0.72-2.02],0.483023127210187
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,16598,73,1.56 [0.73-3.33],0.2541782418199169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,16244,70,1.97 [1.70-2.27],3.28402219420013e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,16627,72,1.62 [0.85-3.11],0.1451245117685901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,16551,73,1.37 [0.64-2.90],0.4150695727800381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,16661,72,1.30 [0.75-2.27],0.3553678950979133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,16471,71,1.08 [0.85-1.36],0.5376154852598063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,16601,71,0.89 [0.73-1.08],0.2326023865437355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,16244,70,1.05 [0.71-1.56],0.795775897306574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,16471,70,1.02 [0.58-1.79],0.9497411262122406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14372,64,1.55 [0.79-3.06],0.2019169743383493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,16689,73,1.06 [0.51-2.21],0.8675784988941794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,16155,71,1.04 [0.75-1.42],0.8279630099961739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14386,64,0.73 [0.45-1.20],0.212867530141753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,13991,59,0.98 [0.48-2.00],0.949455221675958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14372,64,0.81 [0.62-1.08],0.1479606683698028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16187,69,0.82 [0.59-1.13],0.2224638163445715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,13973,61,1.17 [0.65-2.11],0.6068502857487075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,13973,61,0.72 [0.47-1.10],0.1316181530034114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,14009,59,1.74 [1.04-2.91],0.033669031912902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,16496,72,1.60 [0.84-3.07],0.155231836898826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,16598,73,1.14 [0.60-2.17],0.698351602507955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,14009,59,1.58 [0.90-2.75],0.1103278932409937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,14009,59,1.50 [0.84-2.68],0.1667652504899687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,16101,71,1.26 [0.81-1.96],0.3118332756884082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,14178,64,0.91 [0.64-1.30],0.6091837792979571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,16598,73,0.76 [0.46-1.24],0.2714129782247493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,16601,71,1.64 [0.82-3.28],0.1628971165863104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,14386,64,0.98 [0.79-1.21],0.8660364348595025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,14413,64,1.54 [0.62-3.83],0.3480970561575465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,14451,64,0.95 [0.67-1.35],0.7695982651011687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,16703,73,0.92 [0.44-1.92],0.8241236989070277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,14009,59,1.01 [0.75-1.36],0.94600767546061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16497,71,1.12 [0.91-1.39],0.2865533877585671
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16244,70,0.83 [0.57-1.21],0.3285341623525579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,14076,62,0.93 [0.66-1.30],0.6553252013004274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,14413,64,1.08 [0.69-1.70],0.7318933968203931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,13973,61,1.38 [0.99-1.93],0.0584726991210542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,14178,64,0.85 [0.50-1.45],0.5541099772556055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,16187,69,2.82 [2.17-3.67],1.0603776117299476e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14372,64,1.00 [0.79-1.27],0.9770263400280168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,13973,61,1.23 [0.87-1.73],0.2362938386930876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,13973,61,2.16 [1.67-2.80],5.7116040291697125e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,16390,71,1.06 [0.19-5.81],0.9442502840659308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,14431,63,0.96 [0.41-2.24],0.924202581621844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,14421,64,1.35 [0.51-3.53],0.5445859781638853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,13783,58,2.52 [1.09-5.83],0.0301292226008004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,16566,71,0.72 [0.40-1.28],0.2602297164056762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,16551,73,0.87 [0.66-1.16],0.355257461596266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,16187,69,0.98 [0.65-1.47],0.9203958778832246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,14076,62,1.25 [0.72-2.17],0.4269266731077719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,14378,62,0.98 [0.70-1.37],0.8887000315367818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,14064,63,0.76 [0.48-1.21],0.2501372556674676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,13994,60,0.69 [0.36-1.33],0.2695702751369944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,14009,59,1.39 [0.46-4.22],0.5563828104298821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,16550,71,0.55 [0.21-1.42],0.2150564753095093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,14336,64,1.03 [0.74-1.44],0.8604060196867669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16390,71,1.79 [1.58-2.02],1.1663733749043534e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,13939,61,1.14 [0.65-1.99],0.6555478748253134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14413,64,0.82 [0.54-1.23],0.3352649722087178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,16551,73,1.43 [0.58-3.50],0.4358901110147196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,13973,61,0.82 [0.61-1.09],0.1702739156113837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",16155,71,0.90 [0.60-1.34],0.5959623629436255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",13973,61,0.59 [0.29-1.19],0.1383516493123489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",16155,71,1.37 [0.99-1.89],0.054942914859697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,16740,73,37.33 [12.39-112.45],1.2442674810087813e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,14445,64,1.07 [0.34-3.36],0.9037459959492254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,16740,73,1.61 [0.86-2.98],0.1338487360508946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,14195,59,2.43 [1.41-4.21],0.0014457125728084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,16522,72,1.78 [0.99-3.18],0.0522537517266568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,14009,59,0.82 [0.38-1.78],0.6207932598249304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,14009,59,0.90 [0.69-1.18],0.4559898029662101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,14431,63,1.00 [0.59-1.70],0.9952391860554558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,16237,71,1.07 [0.92-1.25],0.3688367253067048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,16497,71,0.92 [0.59-1.42],0.6985309838936685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,13973,61,0.94 [0.50-1.76],0.851203438394251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,16187,69,0.71 [0.49-1.04],0.0818548001105091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,16551,73,0.83 [0.49-1.40],0.4762557947253767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,14445,64,0.56 [0.27-1.16],0.1200791042287886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,16522,72,1.12 [0.61-2.05],0.7145806137797128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,16689,73,0.75 [0.55-1.03],0.074489443676659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,16522,72,4.25 [2.33-7.77],2.54544507191696e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,14451,64,0.84 [0.64-1.10],0.2039555894021059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,14413,64,0.65 [0.28-1.50],0.3164040889162244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,16650,72,1.56 [0.74-3.31],0.2462696251795797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,16551,73,1.60 [0.80-3.22],0.1841043996484789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,16244,70,0.66 [0.42-1.06],0.0843410749289771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,14064,63,0.62 [0.26-1.44],0.2637299246447734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,16661,72,1.22 [0.89-1.68],0.2119341958102407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14431,63,1.11 [0.80-1.56],0.5281389429163501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,14421,64,1.56 [0.89-2.73],0.1199122389423878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,16472,70,1.00 [0.78-1.28],0.987453435084955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,16598,73,0.76 [0.50-1.14],0.1813261371446115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,16497,71,0.67 [0.36-1.23],0.1984617917366344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,16187,69,0.46 [0.21-1.01],0.0534687509101838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,16522,72,1.18 [0.52-2.67],0.6890110692222554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,16661,72,1.36 [0.52-3.57],0.5350013460061471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,16522,72,1.11 [0.93-1.33],0.2347838904190508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,16497,71,1.09 [0.85-1.40],0.4829295450359886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14386,64,1.11 [0.90-1.37],0.3330426458885469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,16655,73,0.71 [0.40-1.28],0.2519143244314292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,16703,73,0.97 [0.70-1.35],0.8599226638510995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14076,62,1.25 [0.54-2.90],0.6061446180617651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,13973,61,1.07 [0.68-1.67],0.7801146177409403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,14343,64,0.92 [0.69-1.21],0.5471133574672433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16459,71,0.83 [0.56-1.22],0.3386484875179385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,16551,73,1.07 [0.71-1.62],0.7350443600293983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,14009,59,0.92 [0.67-1.24],0.5703512713552992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,13973,61,0.60 [0.23-1.51],0.276103642566791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,13973,61,1.08 [0.53-2.23],0.8287820654621539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,16155,71,0.94 [0.54-1.64],0.8366605072842893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,14009,59,0.68 [0.30-1.56],0.3646648205207773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,16342,71,0.77 [0.55-1.08],0.1254276811775093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,14413,64,1.10 [0.63-1.92],0.7433499114246249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,16132,71,1.03 [0.71-1.50],0.8640551214618609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,14178,64,1.02 [0.71-1.47],0.9002973719607089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,14372,64,1.23 [0.88-1.73],0.2275040018413652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,16459,71,2.92 [1.68-5.08],0.0001479376295084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,16551,73,1.05 [0.64-1.72],0.8441740289478162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14178,64,0.93 [0.62-1.38],0.7088051387661035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,13597,60,0.92 [0.75-1.13],0.4221233766121171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,16370,72,1.08 [0.76-1.52],0.6726115799222407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,16601,71,1.11 [0.66-1.86],0.6903915709765948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,16459,71,1.05 [0.77-1.42],0.7779028360005258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,13994,60,0.83 [0.48-1.45],0.5187476177500518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,14421,64,0.96 [0.77-1.20],0.7030668509767486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,14076,62,1.15 [0.81-1.64],0.4273370351447697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,16459,71,0.63 [0.38-1.06],0.0839769392038319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,14405,64,2.40 [0.77-7.48],0.1320575150310209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,14421,64,0.68 [0.43-1.08],0.1011180525139892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,16550,71,1.06 [0.57-1.96],0.8569842682880869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,16432,71,1.18 [0.87-1.60],0.2843120898112204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,16650,72,2.39 [0.86-6.59],0.093391593314338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,14064,63,0.56 [0.26-1.19],0.132107867676118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,13994,60,0.50 [0.25-0.98],0.0426416756856917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,14372,64,0.88 [0.58-1.33],0.5344991439717242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,14413,64,0.90 [0.61-1.33],0.5927330146168766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14076,62,0.95 [0.66-1.36],0.7804979579239514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,16661,72,0.93 [0.80-1.08],0.3539103567923668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,16464,73,0.73 [0.42-1.26],0.2552304798186654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,13973,61,0.80 [0.52-1.22],0.2917150479939751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,16244,70,0.84 [0.54-1.30],0.4359396657680143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,16132,71,1.00 [0.75-1.32],0.98958759912325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,16390,71,1.16 [0.95-1.42],0.1542949636873685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14413,64,1.01 [0.83-1.23],0.92157101994157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14178,64,0.97 [0.60-1.59],0.9173323802192914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16237,71,1.21 [0.84-1.73],0.3004467777211136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,14076,62,1.24 [0.73-2.12],0.4277071226955744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13917,61,1.25 [0.81-1.91],0.3122473491045334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,16155,71,0.79 [0.54-1.15],0.2267897369272892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,14009,59,0.66 [0.30-1.44],0.2952316053596507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,14287,64,1.43 [0.68-3.00],0.3498847290453303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,14421,64,1.08 [0.56-2.08],0.8100324810963727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,13973,61,1.12 [0.85-1.47],0.4214452777957276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,16656,72,1.41 [0.65-3.05],0.3860064325676895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,16551,73,0.32 [0.15-0.68],0.0032867479063366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,16244,70,0.95 [0.60-1.50],0.8246246694838286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,14178,64,0.84 [0.59-1.20],0.3435817914495463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,16551,73,1.14 [0.76-1.69],0.5281804425015937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,16497,71,2.06 [1.85-2.30],2.309623474797799e-40
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,14149,63,1.06 [0.62-1.81],0.8427906268726827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,13939,61,1.66 [0.77-3.59],0.1964963312166021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,16155,71,0.95 [0.62-1.46],0.8255281877418017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14372,64,1.68 [0.89-3.18],0.109143760746437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,13994,60,0.87 [0.62-1.24],0.4497869085846173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14125,63,1.29 [0.79-2.12],0.3115139541658097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,14413,64,1.04 [0.75-1.45],0.8148154249513577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,16651,73,1.64 [0.68-3.93],0.266546300025032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,14413,64,2.23 [0.88-5.63],0.0891077502159183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,16522,72,2.04 [1.19-3.47],0.009119307352553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,14372,64,0.35 [0.15-0.80],0.0133344875549117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,14372,64,4.43 [2.52-7.78],2.38004074874123e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,14386,64,1.41 [0.81-2.45],0.225410528620903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,13939,61,0.92 [0.60-1.40],0.6866303091574557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,14386,64,1.06 [0.64-1.74],0.8248319353206208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,16740,73,1.07 [0.64-1.79],0.8039747732826326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,14372,64,1.03 [0.75-1.41],0.8716406052615799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,14431,63,0.93 [0.72-1.19],0.5568992763316482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16660,73,3.63 [2.94-4.47],2.156636663171703e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,16459,71,1.75 [0.93-3.30],0.0805985500419995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,16661,72,1.19 [0.83-1.69],0.34178930861549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,16522,72,0.90 [0.69-1.18],0.4535050579127989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,13939,61,1.08 [0.70-1.68],0.7167289679233029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13939,61,0.80 [0.46-1.39],0.4218676937525967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",13973,61,1.23 [0.88-1.73],0.2218469307687178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14149,63,0.92 [0.73-1.16],0.4750374497413959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,16740,73,0.70 [0.52-0.92],0.0113613939808048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,16601,71,0.71 [0.56-0.90],0.0046435897569454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,16187,69,0.90 [0.41-1.96],0.7831399086338724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,16522,72,1.50 [0.73-3.07],0.272645560696007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,16740,73,1.81 [0.98-3.36],0.0598639931244394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,13939,61,1.00 [0.55-1.82],0.9992690642780296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,14149,63,0.59 [0.21-1.67],0.3237003545224339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,14445,64,0.89 [0.59-1.33],0.5662178318616312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,13939,61,0.87 [0.56-1.36],0.5341851124824579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,14413,64,1.06 [0.86-1.30],0.5838540854494964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,16601,71,0.91 [0.77-1.08],0.2738701646889847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16187,69,0.92 [0.59-1.46],0.7349498856705392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,14064,63,0.94 [0.58-1.53],0.8135771236716922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13939,61,1.03 [0.67-1.58],0.8970927422486112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,13973,61,0.91 [0.59-1.41],0.6720337139082726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14009,59,1.18 [0.68-2.04],0.5637677458479864
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,16740,73,1.16 [0.47-2.87],0.748700646752968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,16551,73,1.27 [0.89-1.80],0.1823718582501695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,16551,73,1.10 [0.56-2.17],0.7829580508442203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,14076,62,1.05 [0.44-2.51],0.9209037407337374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,14149,63,0.51 [0.22-1.17],0.112848954317231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,14451,64,1.41 [0.56-3.53],0.4599871371756806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,14009,59,0.97 [0.79-1.19],0.7814213955198013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,14357,64,0.74 [0.58-0.94],0.0146637902297426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,16155,71,0.92 [0.63-1.35],0.6593365551266601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,13939,61,0.77 [0.45-1.31],0.3300022320637558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,14064,63,1.03 [0.72-1.48],0.8663712461662354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16427,71,1.35 [1.04-1.75],0.0258462121415269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,14451,64,0.82 [0.63-1.07],0.1490087108847201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14431,63,0.96 [0.61-1.53],0.8737797054419567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,16703,73,1.49 [0.68-3.26],0.3220041972774994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,16679,72,1.03 [0.63-1.68],0.906984354284628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14280,62,0.51 [0.23-1.12],0.0953307054260794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,13973,61,0.73 [0.43-1.22],0.2241312319302122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,14064,63,0.79 [0.48-1.31],0.3615768245509569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,14009,59,1.04 [0.83-1.32],0.7232472059454252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,14413,64,0.94 [0.76-1.17],0.596080999732747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,14372,64,1.10 [0.69-1.75],0.6942448588241426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,13939,61,0.95 [0.72-1.26],0.7161447430367779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16390,71,0.76 [0.38-1.51],0.4313206048383927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14149,63,1.49 [0.84-2.67],0.1758547655704561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,14451,64,1.46 [0.55-3.87],0.4460265925585487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI3,Elafin,16343,71,0.93 [0.63-1.37],0.6980109928020348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14413,64,1.21 [0.90-1.63],0.2064198767814428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,16337,71,0.65 [0.35-1.20],0.1711764091312866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16497,71,2.45 [1.91-3.15],2.102218702934552e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16551,73,3.03 [1.70-5.41],0.0001689487627556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,14009,59,1.21 [0.80-1.82],0.3739662737028395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,16551,73,0.93 [0.57-1.53],0.7797724399338445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,16522,72,0.93 [0.65-1.33],0.6729576690969463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14149,63,0.81 [0.58-1.13],0.2071899031647019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,13917,61,1.08 [0.80-1.44],0.6226869239816013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,14431,63,1.32 [0.53-3.29],0.5566148089382144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,13973,61,1.08 [0.71-1.64],0.7243921513090279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,16559,71,1.43 [1.06-1.91],0.0175801907273314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,14178,64,0.74 [0.53-1.05],0.0908532576240538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,16390,71,0.89 [0.62-1.27],0.5089288304208978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,16598,73,2.58 [1.25-5.34],0.0105957630689563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,16719,72,0.79 [0.50-1.25],0.3196312688125994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",16507,71,0.91 [0.60-1.38],0.6572567520452647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,16601,71,0.84 [0.66-1.07],0.158505859326515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,16551,73,1.39 [0.73-2.65],0.311703898974101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,16702,73,1.02 [0.68-1.54],0.9270457056330568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,16551,73,1.63 [1.01-2.63],0.046090132676944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16429,69,1.45 [0.67-3.16],0.3461944880841177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",14421,64,1.02 [0.68-1.53],0.9065368538156672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",14009,59,0.91 [0.49-1.69],0.7665394062802666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14421,64,0.92 [0.72-1.18],0.5316057097231065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,14421,64,1.10 [0.78-1.55],0.5843314547622545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,14101,60,0.39 [0.13-1.20],0.0997050413695588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,16155,71,0.87 [0.46-1.65],0.6635178788615058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,16522,72,1.02 [0.62-1.67],0.9373682015455308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,16522,72,1.05 [0.77-1.44],0.7487476889773759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,14394,64,0.96 [0.63-1.47],0.8508011357382779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,16688,72,1.26 [0.70-2.26],0.4470100672342812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,16187,69,0.99 [0.51-1.93],0.9707488390831612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,14421,64,1.03 [0.43-2.44],0.9544976722331056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,16497,71,0.87 [0.67-1.13],0.2931483718896042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,16673,73,2.11 [0.95-4.72],0.0674028172841308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,16475,72,0.70 [0.45-1.10],0.1226146857756702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16435,72,0.92 [0.83-1.03],0.1363619867520012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,13973,61,0.70 [0.44-1.12],0.1412762446732416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,13973,61,0.77 [0.50-1.18],0.2306584517540866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,14064,63,1.95 [1.52-2.50],1.0979674257906757e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,16126,71,0.95 [0.79-1.14],0.563371573093612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,14451,64,0.94 [0.64-1.37],0.7484976545614221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,14421,64,1.00 [0.74-1.35],0.9801632827962956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,16522,71,1.02 [0.95-1.10],0.5667500235584478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,14076,62,0.94 [0.60-1.47],0.7923534475048755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,13994,60,1.75 [1.24-2.47],0.0015302743128628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16244,70,0.74 [0.58-0.96],0.0213647473720675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,16459,71,1.25 [0.31-4.97],0.7558681734041763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,16598,73,1.01 [0.48-2.14],0.9728640614886894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,14009,59,1.58 [1.05-2.38],0.0299441982199674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,14009,59,1.39 [0.64-2.98],0.403920267014547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16459,71,2.60 [2.04-3.32],1.2704011391371152e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,14076,62,1.29 [0.91-1.83],0.1450144209663913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,14451,64,0.63 [0.28-1.41],0.259850530133399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,16237,71,1.42 [0.79-2.56],0.2450059434246344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,16601,71,0.63 [0.38-1.04],0.0685771500168913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,14445,64,0.48 [0.25-0.93],0.0301067768844843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,14360,64,0.66 [0.50-0.87],0.002994625742663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,16661,72,1.17 [0.75-1.82],0.4891165517227865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,16569,69,0.93 [0.75-1.17],0.5358017662025237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,14178,64,1.18 [0.86-1.62],0.300259332716313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14445,64,0.96 [0.66-1.41],0.8526550025714211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,14009,59,1.19 [0.57-2.45],0.6456891388045602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,16187,69,0.81 [0.39-1.67],0.5601442739355907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,14009,59,0.86 [0.54-1.39],0.5478993184192731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,14431,63,0.83 [0.52-1.33],0.437450218196403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,16459,71,1.33 [0.94-1.89],0.1056300524542075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14386,64,0.97 [0.72-1.30],0.8338127697080784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16598,73,0.95 [0.76-1.18],0.6491505866314615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14178,64,1.14 [0.85-1.52],0.3831497930371401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14413,64,0.72 [0.52-0.99],0.0452675494636079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14413,64,0.73 [0.37-1.46],0.3764235743115067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,16522,72,1.08 [0.83-1.40],0.578191613124603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,16703,73,1.10 [0.88-1.37],0.3959209782496724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14372,64,1.03 [0.84-1.26],0.7602744395911379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,16390,71,0.74 [0.43-1.25],0.2610288323147748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,14064,63,0.87 [0.60-1.27],0.4781767298099459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,16533,73,0.93 [0.76-1.14],0.4874947587391333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,16187,69,1.86 [1.60-2.16],8.676087638060119e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,13939,61,1.88 [0.82-4.34],0.1385884887087199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,14445,64,1.25 [0.68-2.31],0.4714260342644776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,14386,64,0.52 [0.22-1.23],0.1363782961654932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,16654,72,1.54 [0.84-2.83],0.1618988124593404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,16054,69,1.14 [0.90-1.44],0.2656941483060209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,14194,64,1.47 [1.03-2.09],0.0327587099441033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16244,70,0.96 [0.71-1.29],0.7780554375758568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",16703,73,0.90 [0.66-1.22],0.5057704177092719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,16689,73,1.12 [0.80-1.54],0.5123718186144028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,16244,70,0.67 [0.31-1.47],0.3201685649552102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,16522,71,1.18 [0.48-2.93],0.7162400566156453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,14445,64,1.02 [0.64-1.63],0.9247871263305024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,14445,64,0.55 [0.34-0.88],0.0130997378924548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16244,70,1.10 [0.75-1.63],0.6157722411805975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14064,63,0.98 [0.46-2.10],0.9642061930623904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16522,72,0.83 [0.64-1.06],0.1375501421916019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14391,64,1.08 [0.80-1.46],0.6295455957408325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,16244,70,1.04 [0.65-1.66],0.8810721706757237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,13973,61,0.79 [0.42-1.52],0.4877756714929557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,14149,63,0.94 [0.77-1.14],0.5318122403319623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16187,69,1.72 [1.30-2.28],0.000136066113272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,16661,72,1.03 [0.78-1.36],0.8356835530061404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,14421,64,1.55 [0.99-2.43],0.0548909826717993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,16597,72,0.81 [0.35-1.88],0.6298916658363805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,13973,61,1.32 [0.77-2.26],0.3100660285498731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,16497,71,0.64 [0.42-0.97],0.0369158241531002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,14460,64,0.40 [0.16-0.96],0.0402501408922487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,14039,63,1.12 [0.80-1.57],0.5204418160372238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,14009,59,0.77 [0.42-1.40],0.3936730063108694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,14076,62,2.90 [1.63-5.16],0.0002761669983901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,16627,72,0.87 [0.59-1.28],0.4726064846278378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,14009,59,0.64 [0.28-1.45],0.2871895667254064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,16485,72,0.77 [0.45-1.31],0.3358763355596275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,14421,64,1.39 [0.74-2.62],0.3009539534522037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,16483,69,1.22 [0.73-2.04],0.4458148054094101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16155,71,0.89 [0.74-1.07],0.2257174100145982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,16689,73,1.81 [0.79-4.15],0.1594920718583611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,16119,70,0.83 [0.52-1.32],0.4302480010047887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,14178,64,0.77 [0.32-1.88],0.5714887722605655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,14304,60,1.39 [0.60-3.21],0.4385089382412632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,14372,64,0.99 [0.61-1.61],0.980105594879746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,14372,64,1.10 [0.99-1.22],0.0661334151065098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,16390,71,1.07 [0.89-1.29],0.4868368966780096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,16497,71,1.91 [1.64-2.22],3.018999109753272e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,16187,69,1.02 [0.64-1.63],0.945316360122225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,13939,61,1.48 [0.73-3.00],0.2824664847932516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,14413,64,1.31 [0.85-2.02],0.2160344244573605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,14064,63,0.61 [0.34-1.10],0.1004468141765397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,16459,71,1.23 [0.87-1.76],0.2434517113407572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,16355,69,1.62 [0.93-2.81],0.0892166454737296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,16315,71,1.82 [1.04-3.18],0.0351563575512198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,16497,71,1.69 [1.16-2.47],0.0067914957059603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,14009,59,1.58 [1.12-2.22],0.0087941942847504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,16497,71,0.74 [0.59-0.93],0.0096373288593456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,16187,69,0.70 [0.46-1.06],0.0946969919084878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13676,61,0.91 [0.73-1.14],0.4133540097769025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16155,71,0.68 [0.33-1.37],0.2771906710204699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16439,71,2.85 [1.77-4.57],1.5268186021781865e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,13901,59,0.90 [0.56-1.45],0.669006747125135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,14431,63,0.78 [0.58-1.05],0.1012636416964644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,14064,63,0.89 [0.65-1.21],0.4620358778142073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16497,71,0.84 [0.45-1.56],0.5810190393036221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,16155,71,0.48 [0.30-0.75],0.0014523759656043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,16237,71,0.98 [0.63-1.52],0.9233915719079137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,14009,59,0.98 [0.61-1.60],0.9444580307407482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16390,71,1.43 [1.12-1.83],0.0038015821579972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16576,71,0.93 [0.74-1.17],0.517922617408187
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,13988,59,0.94 [0.48-1.86],0.8620276632744809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,14431,63,0.35 [0.15-0.83],0.0164089354753421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,14445,64,17.22 [10.03-29.55],5.248087220257533e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,16740,73,1.29 [0.63-2.65],0.4800987691614973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,14372,64,1.30 [0.81-2.11],0.2818958502057252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14372,64,1.40 [0.51-3.82],0.5150192341905551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,16474,71,1.77 [0.75-4.17],0.1947587076717092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16340,71,2.19 [1.20-3.99],0.0104581403071847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,14421,64,1.17 [0.63-2.20],0.6192360503774557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,16740,73,6.20 [2.87-13.38],3.3731715902611587e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14431,63,0.67 [0.31-1.44],0.3035103644541717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14149,63,0.91 [0.60-1.37],0.6499990527644275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,16079,70,1.61 [1.17-2.23],0.0038726967433651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,14178,64,1.23 [0.73-2.07],0.4353928513650089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,16497,71,1.75 [1.05-2.92],0.0310204238453441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,16596,73,0.89 [0.74-1.06],0.1842899810843586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,16661,72,0.98 [0.55-1.74],0.9345297471349944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,14386,64,0.85 [0.51-1.41],0.5288552896691394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,16155,71,1.13 [0.77-1.66],0.5356373897940838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,14076,62,1.10 [0.62-1.97],0.7363811850604258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,13973,61,1.04 [0.82-1.32],0.7658491648462916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,14460,64,0.70 [0.40-1.23],0.2119729828597397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,16449,72,1.13 [0.69-1.84],0.6316036440903823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,16594,72,1.34 [0.62-2.92],0.4588363088646087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,14175,61,1.19 [0.73-1.93],0.4917638261915373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,14431,63,0.82 [0.51-1.30],0.3950376297965373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,14431,63,0.95 [0.76-1.19],0.6579943177546778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,14431,63,0.90 [0.68-1.20],0.4738067071857541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,14386,64,0.88 [0.59-1.32],0.5438320708447133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,13973,61,0.91 [0.62-1.34],0.6426240161009551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,16244,70,0.69 [0.49-0.97],0.0317932483584353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,13973,61,0.86 [0.61-1.21],0.3811753927018299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,13994,60,0.69 [0.39-1.21],0.1954474536025864
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,14386,64,0.92 [0.52-1.63],0.7745820023884745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,16497,71,0.76 [0.47-1.22],0.2491896189190914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,16155,71,0.89 [0.56-1.41],0.6203281392439238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,14149,63,1.14 [0.83-1.56],0.4098082840126394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,16187,69,0.63 [0.39-0.99],0.0472352790086025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,16244,70,1.47 [1.06-2.02],0.0192764678486018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,14064,63,0.81 [0.52-1.26],0.3415767064373281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,16187,69,0.80 [0.50-1.29],0.3622606024485438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,14178,64,1.15 [0.80-1.65],0.4603248262161494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,14009,59,1.17 [0.52-2.64],0.7063482268775825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,14386,64,1.75 [1.31-2.35],0.0001673448283254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,14076,62,1.20 [0.76-1.89],0.4309929852844233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,13994,60,1.40 [0.70-2.82],0.343313852228419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,16187,69,0.98 [0.62-1.55],0.927920604737152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,14009,59,1.06 [0.76-1.47],0.7434740707305587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,14178,64,0.96 [0.60-1.53],0.8710685209418658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,16187,69,0.44 [0.19-0.99],0.0476995930017911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,16650,72,0.70 [0.44-1.10],0.1190192591057948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,16155,71,0.71 [0.36-1.38],0.3158245419193289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13939,61,0.98 [0.56-1.73],0.9488596736816294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,16187,69,1.75 [1.47-2.10],7.614019565690113e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,14413,64,1.35 [0.77-2.38],0.2939442944854877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,16129,71,1.82 [1.23-2.70],0.0027236613007481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,14413,64,0.82 [0.59-1.13],0.2256342953647041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,13973,61,1.67 [1.23-2.26],0.0010470097140512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,13939,61,0.88 [0.51-1.53],0.6483718268223382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,14064,63,1.04 [0.75-1.45],0.8135471742788675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,16459,71,0.91 [0.69-1.21],0.5249136420863609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,16459,71,1.37 [0.96-1.97],0.0868088097122852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,14372,64,1.00 [0.67-1.48],0.9956062088341312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,14009,59,0.95 [0.63-1.43],0.8022596488501885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,14076,62,0.94 [0.74-1.20],0.6352866051845496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,14386,64,1.32 [0.92-1.91],0.1339084412473446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,16237,71,1.28 [0.87-1.88],0.2168262963584353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14076,62,1.33 [0.41-4.30],0.6299375590932799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,14413,64,1.02 [0.69-1.50],0.9264470775342508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,16448,71,1.19 [0.79-1.78],0.4020255596184119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,16740,73,1.12 [0.79-1.59],0.5390863306754419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,16740,73,0.96 [0.69-1.34],0.8282861640975251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,14386,64,0.95 [0.51-1.74],0.8586448265969276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,16550,71,1.01 [0.67-1.53],0.9720888138750552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,14009,59,0.68 [0.36-1.27],0.2267460117823223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,16551,73,2.64 [1.44-4.83],0.0016754702430947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REN,Renin,16522,72,0.75 [0.57-0.99],0.0394955614325531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,14009,59,0.66 [0.32-1.34],0.2497703200515362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,13939,61,1.03 [0.51-2.07],0.9328714555807348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16459,71,0.88 [0.51-1.52],0.6424234347960002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RETN,Resistin,16513,72,1.16 [0.72-1.87],0.5474503873854794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",13973,61,0.62 [0.32-1.21],0.1582315213698234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,14386,64,1.45 [0.49-4.29],0.5021345101318562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,14413,64,0.92 [0.67-1.26],0.5935608572934352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14178,64,1.01 [0.69-1.47],0.9674704392337732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,16661,72,2.16 [1.14-4.12],0.0185462342213569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,16661,72,1.94 [0.95-3.97],0.0697590733793061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,14413,64,0.91 [0.60-1.38],0.6604617772732659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,16244,70,0.87 [0.60-1.26],0.4523534461285482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,16290,71,0.94 [0.79-1.13],0.5284149490791574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,14009,59,0.58 [0.28-1.20],0.1403164538904158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14149,63,1.26 [0.78-2.01],0.3423392650658228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,16631,73,1.18 [0.84-1.67],0.3364555145007571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,14431,63,0.90 [0.70-1.15],0.3910051360281114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,13973,61,0.47 [0.26-0.85],0.0117187703030406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,14413,64,0.98 [0.57-1.69],0.9474540766904668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,14120,62,0.62 [0.37-1.05],0.0777432931090855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,14451,64,1.20 [0.49-2.95],0.6867215591142283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,14076,62,0.76 [0.45-1.29],0.3106308528185096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,16456,72,0.92 [0.76-1.12],0.4213688363798508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,13964,61,0.98 [0.39-2.44],0.9571424532552092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,14341,62,1.73 [1.16-2.58],0.0071177837758659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,14413,64,0.98 [0.60-1.58],0.9222763083281056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16674,72,2.62 [1.47-4.67],0.0010925553230827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,14076,62,2.29 [1.34-3.90],0.0024875075293731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,14009,59,1.72 [1.11-2.66],0.0150051195707462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,14009,59,1.18 [0.66-2.12],0.5762400276205389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,14178,64,0.88 [0.60-1.30],0.5260298210201171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,16187,69,1.02 [0.74-1.41],0.8988577931493965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,14178,64,0.50 [0.26-0.97],0.04120649158241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,14076,62,0.89 [0.64-1.23],0.4731395137600751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16550,71,4.65 [2.48-8.74],1.74452400413069e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,16661,72,2.55 [1.08-5.99],0.0322097572901454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,14076,62,1.63 [0.42-6.36],0.4811560331655522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16522,72,6.89 [3.77-12.58],3.304869610420512e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,16459,71,0.94 [0.57-1.55],0.8030861079954171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,14009,59,1.57 [0.88-2.79],0.1269990626396301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,14178,64,1.05 [0.76-1.46],0.7564430020771801
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,14064,63,1.17 [0.69-1.99],0.5631826251986133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,14076,62,2.83 [2.15-3.72],8.9909224620668e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,13973,61,0.76 [0.38-1.52],0.4428206476718078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,14064,63,0.91 [0.75-1.11],0.3504145227941175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,16187,69,1.42 [1.06-1.91],0.019707287033059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16187,69,1.24 [0.91-1.70],0.1770991897537732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,13994,60,1.10 [0.84-1.42],0.4940336972421368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,16390,71,1.05 [0.56-1.98],0.8767136231007857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,16689,73,1.32 [0.63-2.75],0.4572812225371508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,16459,71,0.57 [0.27-1.20],0.1383154113197004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,13973,61,0.56 [0.29-1.10],0.0914688568976388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14413,64,0.98 [0.75-1.27],0.8663472783726521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,16689,73,1.31 [0.72-2.38],0.3699978076039458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,16187,69,0.99 [0.80-1.22],0.9088092099974456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,16661,72,1.03 [0.74-1.44],0.8397963929198273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,13973,61,0.95 [0.46-1.92],0.8774106728988619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,16407,72,1.04 [0.67-1.60],0.8731985012142336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,16311,71,1.21 [0.92-1.59],0.1824830512943303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,14009,59,1.40 [0.74-2.67],0.3045329104528292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,14413,64,0.79 [0.49-1.28],0.3487574297624645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,16132,71,0.74 [0.51-1.08],0.1204865005075861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,14386,64,1.47 [1.11-1.95],0.0065009723996465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,16598,73,0.91 [0.63-1.32],0.6340663631726142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,14413,64,0.62 [0.35-1.09],0.094600151919523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,16237,71,0.88 [0.59-1.32],0.5373820765091494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,14460,64,0.37 [0.08-1.85],0.2283876842196453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,14413,64,2.37 [1.71-3.28],2.1791334956525322e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,13994,60,0.63 [0.37-1.07],0.0854940230365232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,16497,71,1.05 [0.78-1.40],0.7637374051059412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,14178,64,1.00 [0.72-1.38],0.9785126728206632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,14372,61,0.91 [0.73-1.14],0.4228539336757602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,13973,61,2.36 [1.89-2.94],2.448209799045937e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,13973,61,0.61 [0.32-1.17],0.1356038319586514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,14178,64,1.01 [0.70-1.45],0.967701591392903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,14413,64,1.10 [0.51-2.35],0.8092335095711811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,14415,64,0.92 [0.46-1.82],0.8021057850731272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,16459,71,1.35 [1.06-1.71],0.0134178016161838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,16661,72,0.95 [0.47-1.92],0.8939290145351059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,16155,71,0.89 [0.59-1.35],0.5782590311896607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,16082,68,1.82 [0.99-3.34],0.0537902914283061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,16740,73,0.75 [0.45-1.25],0.2773706969515299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,16661,72,2.16 [1.10-4.25],0.0253865126858145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,16597,73,1.26 [0.67-2.37],0.4663845021703228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,16550,71,0.76 [0.41-1.41],0.3879731793701847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,16540,69,1.15 [0.76-1.72],0.5112779235245675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,13973,61,0.80 [0.33-1.93],0.6261978215417977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,14149,63,1.28 [0.50-3.26],0.6054030901241436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,16576,71,0.92 [0.70-1.20],0.5498438593925568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,16244,70,1.59 [1.02-2.48],0.0404213165846143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,13994,60,0.90 [0.63-1.29],0.5771055269654823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,16631,73,1.23 [0.79-1.91],0.3544523744109317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,13994,60,0.96 [0.57-1.63],0.8771668721602587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,14064,63,0.72 [0.29-1.82],0.4891159322629766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,14064,63,0.73 [0.34-1.56],0.4117463556178673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,13994,60,1.18 [0.76-1.84],0.4698090649019685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,14076,62,1.11 [0.62-1.98],0.7281410789557283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,16187,69,0.76 [0.53-1.09],0.1393506557738247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,14022,62,0.87 [0.52-1.45],0.5968441267607382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,14431,63,0.65 [0.26-1.63],0.3545135401663335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,14076,62,1.23 [0.98-1.53],0.0694444396502703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,16497,71,1.39 [0.99-1.95],0.0605275621131353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCT,Secretin,14064,63,0.84 [0.50-1.42],0.5212135318289585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,16522,72,1.16 [0.69-1.97],0.5730636202647512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,16522,72,0.32 [0.21-0.48],3.1541175755387586e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,14386,64,1.08 [0.87-1.34],0.4826239508300991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,14372,64,1.12 [0.79-1.59],0.5358598519573982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,14149,63,3.93 [3.33-4.65],1.3448819179765513e-57
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,14076,62,1.04 [0.75-1.44],0.8088655924479484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,14076,62,1.10 [0.51-2.37],0.81447422084607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,16740,73,1.21 [0.80-1.83],0.3618802031687236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,14460,64,0.35 [0.12-1.01],0.0527186964786599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,14460,64,17.72 [11.63-27.01],8.05139788816552e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,16627,72,0.77 [0.53-1.13],0.1843914134963207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,16497,71,1.97 [0.84-4.63],0.1210591133802342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,16522,72,1.21 [0.54-2.67],0.6454913024957385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,14149,63,2.18 [1.40-3.37],0.0005017682139168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,16459,71,1.23 [0.62-2.43],0.5589230440795234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,16661,72,1.57 [0.78-3.17],0.2073126164257041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,14009,59,0.79 [0.28-2.23],0.6562226737132149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16702,73,8.18 [6.44-10.38],1.0387267439586668e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,14413,64,0.83 [0.59-1.16],0.2813446560635534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,14178,64,0.79 [0.46-1.35],0.3869226666064808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,14396,64,2.01 [1.13-3.57],0.0175110983922259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,16459,71,2.55 [1.64-3.96],3.208039901539338e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,14163,62,5.00 [0.86-29.14],0.0735644690393255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,16740,73,0.93 [0.56-1.54],0.7671863780928101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,16034,71,0.83 [0.64-1.06],0.1397301854715835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,14400,62,1.78 [0.44-7.28],0.4204249443668985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,14177,60,0.44 [0.16-1.21],0.1125518990715852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,14230,62,0.53 [0.21-1.30],0.1647607662749526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,14460,64,2.45 [0.55-10.87],0.2368951586694232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,14460,64,1.71 [0.48-6.07],0.4055268950796321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16372,71,0.72 [0.53-0.97],0.0335715832885916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,16499,71,0.91 [0.72-1.16],0.4541701808824662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,16237,71,1.18 [0.76-1.83],0.4627550713306252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,16605,72,0.87 [0.60-1.25],0.4427479284621561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,16703,73,1.49 [1.19-1.87],0.0004290818807703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,16390,71,1.01 [0.53-1.92],0.972641422989944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,14433,64,1.09 [0.22-5.51],0.9171017308945992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,14433,64,0.71 [0.30-1.68],0.4395794635995813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,16740,73,0.72 [0.53-0.97],0.0307730964554939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,14431,63,0.62 [0.42-0.92],0.0180364307317678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,14229,64,0.88 [0.35-2.21],0.7846791395737782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,14171,64,0.33 [0.06-1.88],0.2104334007375459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,14433,64,0.76 [0.20-2.84],0.6848917327660979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,14178,64,1.01 [0.84-1.22],0.8854860628025442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,14125,63,1.04 [0.46-2.36],0.9304319584900425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,14372,64,1.23 [0.81-1.87],0.3274722684826294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16155,71,0.87 [0.62-1.22],0.4153287333770531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,16337,70,2.43 [1.42-4.15],0.0012077141194032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,14064,63,1.48 [0.74-2.95],0.2633048875663659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,16598,73,1.56 [0.75-3.27],0.2357624331923068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,16459,71,1.21 [0.50-2.93],0.6682953014682917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,16459,71,1.11 [0.84-1.47],0.4420158340626487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,16341,71,0.63 [0.37-1.07],0.0895609356612393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,14149,63,1.51 [0.82-2.81],0.1889577147294117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,16187,69,0.99 [0.67-1.47],0.978435300883721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,16187,69,1.48 [1.01-2.16],0.0418815830226456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,16522,72,1.09 [0.80-1.48],0.5890690830112064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,14165,60,0.75 [0.47-1.20],0.228859950348886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,16187,69,0.90 [0.72-1.12],0.3524591902279298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,16497,71,1.11 [0.79-1.56],0.5327404111272689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,13994,60,0.74 [0.44-1.23],0.2451832809544171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,14372,64,1.18 [0.78-1.80],0.4388016897917425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,14106,64,1.03 [0.78-1.38],0.8195963121433658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,14421,64,1.24 [0.87-1.76],0.230533654388101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,14451,64,1.03 [0.63-1.70],0.8991708841488423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,13939,61,0.75 [0.58-0.97],0.025606291137614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,13941,61,0.81 [0.56-1.17],0.2664602487566599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,14009,59,0.95 [0.52-1.72],0.8642819891644955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,14445,64,1.84 [0.85-3.96],0.1204218704505235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",16576,71,0.89 [0.69-1.15],0.3807262739629172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,14178,64,0.92 [0.50-1.71],0.7893139461308861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,16576,73,0.73 [0.46-1.16],0.1801954013955059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,16601,71,1.75 [1.08-2.83],0.0221247674049858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16497,71,13.74 [10.29-18.34],9.988614975277378e-71
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,16155,71,0.66 [0.44-0.98],0.0378299275139436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,16551,73,1.58 [1.22-2.04],0.0004850846074787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16689,73,7.24 [5.39-9.72],1.2965239873200348e-39
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,16522,72,0.81 [0.37-1.75],0.5915566685392466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,14076,62,2.04 [1.20-3.45],0.0081401709805265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,16661,73,0.70 [0.35-1.39],0.3081513966850418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,14076,62,0.57 [0.20-1.61],0.2858199703781188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16591,71,1.18 [0.80-1.74],0.3944418572219661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,16505,71,1.00 [0.64-1.57],0.9902496200012076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,14009,59,1.30 [1.06-1.58],0.0099442284099665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,16459,71,0.99 [0.78-1.26],0.9403430319247712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16155,71,0.80 [0.51-1.24],0.3111872700350237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,16244,70,1.99 [1.38-2.86],0.0002124245058793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,16361,71,1.08 [0.81-1.44],0.6078743499040922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,16601,71,0.88 [0.72-1.07],0.1980160704864885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,13973,61,0.67 [0.32-1.40],0.2892442931876118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,14413,64,0.86 [0.68-1.08],0.1972828713615887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,16244,70,1.23 [0.86-1.78],0.2605996980262453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16187,69,7.99 [6.27-10.18],1.7655235482802582e-63
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,16497,71,0.71 [0.49-1.02],0.0654256805872673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,16187,69,1.86 [1.26-2.74],0.001727645907303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,13973,61,1.13 [0.47-2.72],0.7912460847487702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,14386,64,0.58 [0.31-1.09],0.0919685508738932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,16155,71,1.16 [0.83-1.62],0.3965212507747371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,14064,63,0.84 [0.49-1.44],0.5172061611415733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,16155,71,1.03 [0.75-1.40],0.8746962401525245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,13939,61,1.05 [0.71-1.57],0.7963763458167421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,13939,61,0.97 [0.57-1.63],0.8951902636425045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,16155,71,1.25 [0.71-2.20],0.4318313871152167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,16497,71,1.14 [0.78-1.66],0.508327478168005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,14064,63,0.55 [0.32-0.95],0.0310617235871733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,14445,64,1.55 [0.97-2.46],0.0670276292800424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,13973,61,0.98 [0.70-1.36],0.8910739120350055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14149,63,0.89 [0.66-1.19],0.4238413822365221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14372,64,1.07 [0.68-1.67],0.7775697942639364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13939,61,0.81 [0.49-1.33],0.396494150553452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,16155,71,0.84 [0.54-1.29],0.4183230848572482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,14009,59,1.49 [0.69-3.24],0.310824920321053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16689,73,2.07 [1.26-3.41],0.004025301173321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,16237,71,1.35 [0.75-2.43],0.3114526246867881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,14178,64,0.83 [0.57-1.21],0.3340540741938548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,14372,64,1.09 [0.82-1.45],0.5665104305313255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,14328,64,0.91 [0.46-1.81],0.7906741268474784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,16187,69,0.86 [0.66-1.13],0.2777591591481438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,14386,64,0.85 [0.60-1.22],0.3866437804823479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,14386,64,1.20 [0.77-1.87],0.4270976162739043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,16459,71,0.45 [0.17-1.20],0.1108868421083112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,16155,71,0.84 [0.61-1.15],0.2838294478322651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,13939,61,1.36 [0.95-1.96],0.0967562856039876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,14372,64,2.16 [1.87-2.48],6.49841137810142e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,16689,73,1.47 [0.79-2.74],0.2264149847468848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,16601,71,1.18 [0.68-2.03],0.5620157372600303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,16574,72,0.64 [0.41-1.00],0.0506405524865783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,14009,59,0.94 [0.58-1.51],0.7902832863506555
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16584,71,0.88 [0.64-1.20],0.4117298721777481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14386,64,0.48 [0.28-0.82],0.0068065825092735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,13994,60,1.16 [0.82-1.63],0.4131782065875221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,14404,64,0.90 [0.68-1.19],0.4560176100421083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,16522,72,0.88 [0.70-1.11],0.2913392171240332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,13994,60,1.07 [0.64-1.81],0.7878619806356059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,16598,73,0.90 [0.72-1.13],0.3567677162274996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,14413,64,1.28 [0.86-1.91],0.2256788071993814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,14149,63,0.88 [0.71-1.09],0.2462202096232257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,16390,71,1.06 [0.77-1.45],0.7258223337149428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14076,62,0.43 [0.18-0.99],0.0480633268998803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',14421,64,1.87 [1.58-2.22],8.59522491436247e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,13973,61,1.57 [1.23-1.99],0.000228382265947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,14149,63,1.24 [0.80-1.92],0.3365750491503925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,14372,64,1.19 [0.71-2.00],0.497351152635455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,14386,64,1.20 [0.94-1.54],0.1340795102212867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,14076,62,1.25 [0.56-2.78],0.5850934883147649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,16522,72,1.15 [0.85-1.56],0.3749996343606591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],16248,70,1.04 [0.67-1.63],0.8538242147087535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",16551,73,1.28 [0.76-2.16],0.3469015012334188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,14451,64,0.91 [0.58-1.44],0.6997768442148242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,14413,64,1.02 [0.57-1.83],0.954070869025305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,16187,69,1.61 [0.89-2.90],0.1159042140628224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,16607,73,1.12 [0.81-1.53],0.4930197399317341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,16496,72,0.73 [0.41-1.30],0.2848847477417535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,16496,72,1.10 [0.64-1.88],0.7304107507016923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14064,63,1.23 [0.85-1.80],0.2757805498113255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,14384,64,1.08 [0.41-2.84],0.8781710403903997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,14064,63,1.45 [0.59-3.59],0.4213796906937482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14413,64,1.83 [1.04-3.22],0.034727332961362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,14413,64,0.98 [0.64-1.50],0.932349052789095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,16598,73,0.85 [0.65-1.13],0.2677671147037726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,16571,72,1.73 [1.03-2.90],0.0383219302512928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPART,Spartin,14149,63,0.82 [0.59-1.14],0.2301155021604015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,14431,63,2.50 [1.33-4.70],0.0043169387855916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,16551,73,1.11 [0.68-1.81],0.6882440259076368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,14149,63,0.83 [0.42-1.66],0.6028847637653351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,16497,71,0.92 [0.66-1.27],0.6127440224370777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,16551,73,0.61 [0.33-1.15],0.1248918950855783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,16689,73,1.16 [0.78-1.72],0.4636979093443258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,13973,61,1.37 [0.86-2.18],0.1890598158817985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16507,72,5.22 [2.79-9.79],2.522189204799016e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,16601,71,0.67 [0.40-1.12],0.1251338567314603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,14372,64,0.89 [0.77-1.03],0.1055458908304051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,16390,71,0.32 [0.14-0.73],0.0068332006958388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,16550,71,0.63 [0.32-1.23],0.1780122149908124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,16455,72,1.33 [0.73-2.43],0.3556610308286593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,16717,72,1.08 [0.67-1.72],0.754793084602204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",14009,59,1.14 [0.65-2.00],0.6577399646447426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,13939,61,1.50 [1.17-1.92],0.001489824879317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,14178,64,0.90 [0.65-1.25],0.5326571644679285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,14421,64,0.86 [0.60-1.24],0.421933731497888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,16244,70,0.93 [0.73-1.18],0.5351000710382137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13994,60,2.96 [2.12-4.12],1.3423191269173987e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,14421,64,0.69 [0.33-1.46],0.3325985470155279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,16569,73,0.89 [0.75-1.06],0.1886394294061177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,16459,71,2.67 [2.18-3.27],1.6260187220975329e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,16497,71,1.24 [0.98-1.56],0.0694636914658344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,14431,63,0.71 [0.38-1.31],0.2703153166447726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,16155,71,1.04 [0.74-1.46],0.831851418284161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",14009,59,0.95 [0.45-2.01],0.9000252133456735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16496,72,1.04 [0.87-1.24],0.6866997636938976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16627,72,0.88 [0.54-1.45],0.6190865532056301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,13939,61,0.86 [0.36-2.10],0.7454662342238791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,14372,64,1.22 [0.78-1.90],0.3926768793405524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,14149,63,1.18 [0.76-1.83],0.4523072896939258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16459,71,1.72 [1.21-2.46],0.002753615395844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16740,73,0.68 [0.33-1.40],0.2981413661005955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",14009,59,0.63 [0.31-1.30],0.2129100698720336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,14445,64,0.73 [0.31-1.70],0.4601729959726103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,14386,64,0.70 [0.34-1.44],0.3331183656192892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,16361,71,1.09 [0.78-1.52],0.6050218489442307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,14009,59,1.19 [0.86-1.65],0.292475514075239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,16459,71,0.94 [0.81-1.10],0.4344133747626757
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13939,61,0.77 [0.50-1.20],0.2504331536760985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16661,72,6.47 [5.39-7.77],3.0966631306865704e-89
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,16534,73,4.35 [1.81-10.45],0.0010030261832877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,13994,60,0.54 [0.32-0.89],0.0168399683823923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,16529,73,1.21 [0.89-1.65],0.2214313719587203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,16237,71,0.94 [0.70-1.26],0.6837915068610119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,16155,71,0.84 [0.59-1.19],0.3302100843058325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,16522,72,0.88 [0.69-1.12],0.3005405159983835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",13939,61,1.06 [0.83-1.37],0.6373555924014529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,16187,69,0.75 [0.49-1.15],0.1857102551229812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,14064,63,0.87 [0.45-1.70],0.6883433884191645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,14421,64,0.74 [0.36-1.52],0.4170176220424235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,16459,71,1.03 [0.73-1.45],0.8789729849884065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,14009,59,1.17 [0.67-2.04],0.5883370474393155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,16187,69,0.93 [0.66-1.31],0.6956948852250642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,14009,59,1.93 [1.17-3.17],0.010031459846074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,16497,71,0.83 [0.52-1.32],0.4284419996165544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,14413,64,0.85 [0.62-1.15],0.2876564872312379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,16187,69,0.90 [0.54-1.51],0.6950225646507718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,14372,64,1.40 [0.81-2.42],0.2331152732337041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,16187,69,1.04 [0.79-1.36],0.8002694451296531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,16661,72,0.90 [0.77-1.05],0.1841070480545059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,16497,71,0.88 [0.59-1.31],0.5332368334002331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,14009,59,0.68 [0.38-1.22],0.1984653382724289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16661,72,0.96 [0.65-1.43],0.8433255714290581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",14413,64,1.13 [0.79-1.63],0.5000458883209973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,16237,71,0.73 [0.48-1.11],0.1396121547492041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,16551,73,1.08 [0.52-2.23],0.8451194686228556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,14386,64,1.08 [0.61-1.91],0.8027926471712229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,14069,60,2.31 [1.12-4.77],0.0241805454845949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,14064,63,0.64 [0.41-1.02],0.0607988759412969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,14372,64,2.64 [2.03-3.45],8.878308401744152e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,14149,63,0.62 [0.39-1.00],0.0487096323060019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,13994,60,0.66 [0.38-1.14],0.1325231051439383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,14421,64,0.96 [0.53-1.74],0.8947217507224984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,14431,63,0.91 [0.64-1.28],0.583721686930776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14178,64,0.98 [0.78-1.23],0.8413353789641866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,16459,71,0.93 [0.77-1.11],0.4053853350353148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,14675,65,1.26 [0.58-2.70],0.5614278846561838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,14386,64,0.97 [0.53-1.78],0.9263603460835712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,16459,71,0.78 [0.43-1.42],0.4250662332221598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,13939,61,1.07 [0.72-1.57],0.749232832993604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,14382,62,1.08 [0.62-1.87],0.7837397009745073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,16244,70,1.02 [0.75-1.39],0.8994239324010902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,14178,64,0.38 [0.21-0.71],0.0022524006932776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,16155,71,0.99 [0.76-1.30],0.962918935216988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14064,63,0.68 [0.45-1.05],0.0816379358628109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14386,64,1.21 [0.67-2.19],0.5317176476237906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,14421,64,1.73 [1.26-2.37],0.0006895490167794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,16155,71,1.46 [1.00-2.13],0.0511807233192165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,16459,71,0.89 [0.70-1.13],0.3302591775417325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,16497,71,0.99 [0.76-1.29],0.929158965559956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,14149,63,1.01 [0.75-1.35],0.9646030091206688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,16390,71,0.95 [0.77-1.17],0.6144265253357167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,16390,71,0.85 [0.66-1.11],0.2325652245721755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,16187,69,0.89 [0.69-1.15],0.3816273025762181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,14064,63,0.74 [0.39-1.39],0.3479955849274876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,16373,71,3.00 [2.62-3.43],3.3574615920519584e-57
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,16237,71,1.05 [0.82-1.34],0.7235054554472629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,14146,62,1.05 [0.52-2.14],0.8892814559538358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,16717,72,1.60 [0.87-2.95],0.1314920947536949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,14431,63,3.64 [2.87-4.62],1.4980314918843158e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,14178,64,0.98 [0.63-1.52],0.9260252769354548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,14431,63,1.22 [0.54-2.75],0.6270285748835918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,16155,71,1.07 [0.93-1.23],0.367111303141546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",14064,63,1.00 [0.53-1.90],0.9994235436161496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,14386,64,1.69 [1.41-2.03],2.6020841889904654e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,16155,71,1.13 [0.89-1.44],0.3121056421732426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,13973,61,0.97 [0.55-1.73],0.9206002742964025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,16598,73,4.98 [2.09-11.90],0.0002975156927047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,14009,59,1.56 [0.73-3.33],0.2506081384719353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,14142,64,1.03 [0.82-1.29],0.7795973631807173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,14064,63,1.11 [0.73-1.71],0.6240279260133461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,14178,64,0.84 [0.41-1.70],0.6248235321269721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,14460,64,0.53 [0.18-1.60],0.2599175593956939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,13994,60,0.89 [0.58-1.38],0.6134529478892734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,16474,71,0.90 [0.68-1.19],0.455129836911963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,16576,71,0.81 [0.55-1.20],0.2967705645052232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,16539,72,0.98 [0.56-1.72],0.9537003472800488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,16528,71,0.91 [0.45-1.83],0.7915839199195794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,16555,73,1.01 [0.58-1.76],0.9799703816527484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,16621,72,2.45 [1.54-3.91],0.0001691629492387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,14386,64,0.91 [0.72-1.14],0.4009016061567678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,16497,71,1.41 [0.92-2.17],0.1172021453823395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,16678,73,0.80 [0.46-1.39],0.4272795338416123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,14386,64,1.40 [0.95-2.05],0.0891144019692209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,16471,71,1.53 [0.71-3.30],0.2774382799411128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,14009,59,1.98 [0.88-4.45],0.1007755515525869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,16598,73,1.65 [0.94-2.90],0.0791672790164341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,16740,73,1.35 [0.69-2.64],0.3886047983999605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,16503,72,1.41 [1.08-1.85],0.01237137708651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,14451,64,4.35 [2.09-9.03],8.278410464985627e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,13917,61,1.19 [0.95-1.50],0.1269268787838657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16522,72,2.72 [1.88-3.93],1.0763656785686069e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,16551,73,0.81 [0.45-1.45],0.4740154259821245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,16566,71,1.05 [0.66-1.67],0.8437631003591786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,16435,72,2.08 [1.19-3.64],0.0097881831264484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,16237,71,1.06 [0.62-1.82],0.8303056796934831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,13973,61,0.97 [0.77-1.24],0.8312186137043633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,13897,59,1.21 [0.60-2.43],0.5962997544925717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,14361,64,0.94 [0.71-1.24],0.6666292323237193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,16661,72,2.34 [1.18-4.63],0.0143799354501907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,16058,71,0.96 [0.81-1.15],0.6759855177973957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,16740,73,3.22 [1.58-6.56],0.0012633131823525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16126,71,1.98 [1.43-2.75],3.668308278010441e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14178,64,1.67 [1.28-2.17],0.0001378350271968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16627,72,3.01 [2.04-4.45],3.4009891564536335e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14431,63,0.83 [0.45-1.56],0.5705879731337337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14421,64,1.21 [0.92-1.60],0.1695447357817695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,16395,71,0.73 [0.33-1.57],0.414724736296668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,14431,63,0.61 [0.20-1.85],0.3795422312267321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,16601,71,0.85 [0.72-1.01],0.0617497721709547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,16551,73,0.48 [0.28-0.85],0.0112260493619812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,16472,72,2.00 [0.78-5.15],0.150133182811528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,16598,73,0.97 [0.75-1.25],0.8106644922135928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,13994,60,0.96 [0.53-1.74],0.8976239648270404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",14178,64,1.60 [1.09-2.34],0.0155070389459986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,14009,59,2.34 [1.08-5.08],0.0318776847909005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,14178,64,1.91 [0.70-5.26],0.2076791170797556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,16703,73,0.91 [0.65-1.27],0.5831250845624807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,14009,59,1.51 [0.65-3.48],0.3374801351753942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14064,63,0.96 [0.61-1.50],0.8512913867458256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,14178,64,0.75 [0.46-1.24],0.2686019874938509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,13973,61,0.31 [0.11-0.84],0.0206428822630706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,13973,61,0.74 [0.43-1.27],0.2711240897576396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,14372,64,0.98 [0.77-1.24],0.8558960575763497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,14386,64,0.81 [0.57-1.16],0.2498318909248131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,14076,62,0.75 [0.50-1.11],0.1500034890613933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,14413,64,1.44 [1.02-2.04],0.0393762321411354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,13939,61,1.02 [0.55-1.90],0.9542599973214952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,13994,60,0.56 [0.35-0.90],0.0165443607489919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,14396,64,0.59 [0.33-1.08],0.0854591091836954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,16459,71,0.88 [0.70-1.12],0.3005259737569453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,16318,71,1.17 [0.67-2.05],0.5789129168000788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,16551,73,1.27 [0.96-1.67],0.0928543060757879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,16627,72,1.41 [0.92-2.15],0.1103444900796626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16212,71,1.79 [1.36-2.36],2.880744412199344e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14372,64,1.08 [0.66-1.77],0.7476729502076132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16244,70,1.04 [0.59-1.85],0.8846033890998788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14149,63,0.68 [0.45-1.04],0.0742086673466863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16390,71,2.40 [1.66-3.48],3.754808721740204e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16390,71,1.51 [1.25-1.82],1.703469332328457e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16581,71,0.93 [0.61-1.43],0.7553563211054936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16703,73,1.38 [0.83-2.30],0.21506514181461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16522,71,1.66 [0.82-3.36],0.1556646162654719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16598,73,1.42 [0.81-2.51],0.2243246647826993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16550,71,5.99 [4.84-7.42],8.961038167711283e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16244,70,6.15 [3.88-9.75],1.0799693184001736e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16550,71,1.75 [0.93-3.29],0.0843962472043945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14149,63,3.15 [1.81-5.47],4.957324136763261e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16689,73,1.83 [1.03-3.24],0.0396364076116525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16551,73,2.28 [1.27-4.10],0.0057333336513702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16551,73,1.78 [1.36-2.35],3.326712064431864e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16661,72,1.94 [0.94-3.97],0.0714312158090264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16678,73,4.84 [3.36-6.96],1.9627899239920938e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16390,71,1.23 [0.87-1.75],0.2395727413182325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16661,72,2.22 [1.57-3.15],7.011128307447489e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16390,71,4.69 [3.90-5.64],8.813977141758922e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,16703,73,0.82 [0.36-1.86],0.6345361842698737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,16497,71,1.17 [0.83-1.67],0.3650564652309452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,16703,73,0.66 [0.31-1.40],0.2797448977111429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,16601,71,0.43 [0.25-0.72],0.0016480177725815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16720,73,0.40 [0.27-0.59],5.678490834171765e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,16390,71,0.95 [0.65-1.37],0.7742563223162967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14445,64,3.30 [2.14-5.10],7.398025890644867e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,14421,64,1.28 [0.99-1.66],0.0612893096222767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,14445,64,0.91 [0.52-1.57],0.7257200419079708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",16237,71,0.99 [0.77-1.27],0.907728544896925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,14178,64,1.60 [0.96-2.65],0.0692009074062865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,16390,71,0.88 [0.53-1.45],0.6177630575985928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,16551,73,0.77 [0.34-1.73],0.5265432169275059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14431,63,0.97 [0.70-1.33],0.827405733599811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,14372,64,0.90 [0.73-1.11],0.326117094068812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",13939,61,0.84 [0.48-1.47],0.5500267807639605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,14009,59,1.67 [1.28-2.18],0.0001756368502473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,14076,62,1.20 [0.80-1.79],0.3842275182741802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,16187,69,2.13 [1.39-3.25],0.0004894797864918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,14009,59,1.73 [1.35-2.24],2.074455288845872e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,13838,60,1.10 [0.69-1.78],0.6824556312532724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,16237,71,0.84 [0.39-1.81],0.6625935043484564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,14064,63,1.56 [0.78-3.13],0.2118711824399378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,14064,63,0.61 [0.30-1.22],0.1601339848807935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,14149,63,0.88 [0.70-1.09],0.2399829166429636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,14431,63,4.11 [1.84-9.18],0.0005618031368166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,13973,61,0.65 [0.34-1.22],0.1774338932412281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,16187,69,1.09 [0.82-1.45],0.5680343268545072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,16412,69,0.72 [0.43-1.20],0.202786164136924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,14178,64,0.74 [0.51-1.07],0.109804844864192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,16155,71,0.56 [0.29-1.09],0.0867931696398084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,13973,61,1.76 [1.42-2.17],1.4600764894016394e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,13939,61,1.18 [0.88-1.58],0.258277300976955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,16680,73,1.10 [0.74-1.64],0.6220776539139947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,14413,64,0.84 [0.42-1.66],0.6099121045449597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,14009,59,1.30 [0.53-3.21],0.5712102848588076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,16244,70,0.93 [0.66-1.32],0.6911210980197338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,16497,71,1.19 [0.89-1.61],0.2412888568822071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",14009,59,1.98 [1.30-3.01],0.0013564525122799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,13973,61,0.82 [0.46-1.49],0.5231605905460858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14178,64,1.07 [0.82-1.40],0.6095016364383783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,14445,64,1.17 [0.84-1.63],0.3475936628807684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,16522,71,1.50 [1.03-2.21],0.0368293138162808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,14451,64,0.76 [0.48-1.22],0.2627024289022093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,16551,73,10.52 [6.89-16.06],1.0643213344166317e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,16689,73,1.15 [0.82-1.59],0.4214421641239589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,16497,71,0.88 [0.68-1.16],0.3677972550625722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,14154,64,1.20 [0.85-1.70],0.3006473349709613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14372,64,1.06 [0.85-1.32],0.6167389109551231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,13939,61,0.96 [0.61-1.52],0.876784374953026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,14064,63,0.71 [0.50-1.02],0.0627970137769484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,16497,71,0.99 [0.77-1.26],0.90514915531608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,14386,64,1.03 [0.78-1.36],0.8297054307159263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,13973,61,0.47 [0.25-0.88],0.0192131520184123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,14009,59,0.90 [0.62-1.32],0.5941409692470496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,14413,64,1.00 [0.69-1.44],0.9877245553116172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,16522,72,1.17 [0.90-1.52],0.2318230446441583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,16237,71,0.94 [0.65-1.36],0.7403376537564896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,13973,61,0.98 [0.53-1.84],0.9595418632170044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,16237,71,0.92 [0.69-1.22],0.5603397689052392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,13973,61,0.73 [0.41-1.32],0.2954647264216086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,13994,60,0.83 [0.60-1.14],0.2414599941965076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,14372,64,0.91 [0.71-1.17],0.4781934249773332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,14009,59,0.89 [0.46-1.70],0.7172483172996229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,16119,71,1.03 [0.78-1.37],0.8117623035714089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,14064,63,0.98 [0.60-1.62],0.9496837801007966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTN,Titin,13973,61,1.15 [0.83-1.59],0.401714205427693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,14302,62,0.33 [0.13-0.85],0.0217339181606736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,13994,60,1.02 [0.43-2.44],0.95750311307741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,14445,64,0.95 [0.71-1.27],0.7367343100741033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,14178,64,0.91 [0.65-1.28],0.5950348983763345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,16390,71,1.18 [0.93-1.51],0.1727032363610423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,14208,62,1.10 [0.65-1.88],0.7197469335480349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,16598,73,0.45 [0.21-0.97],0.0407119594128052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,16661,72,0.90 [0.65-1.23],0.4961720267932177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,14421,64,0.92 [0.57-1.47],0.7138502929052327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,13968,60,0.96 [0.74-1.24],0.752121306873734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16551,73,0.92 [0.58-1.46],0.7321322179548615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,16412,71,0.89 [0.64-1.23],0.4850416408789401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,16522,72,1.22 [0.58-2.55],0.5996749236638903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",14009,59,1.36 [0.91-2.05],0.1349234444614968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,16459,71,2.16 [1.18-3.93],0.0119765422691771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,14386,64,1.48 [0.74-2.98],0.2712675479303982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14431,63,1.16 [0.78-1.72],0.457860748300735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,14009,59,0.73 [0.44-1.21],0.2182747363824786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,13973,61,0.86 [0.51-1.43],0.5574091701392357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,14149,63,1.02 [0.71-1.46],0.9100604876986724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14372,64,0.93 [0.78-1.10],0.4012909226190899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,13973,61,0.92 [0.69-1.21],0.5389532022539955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,13973,61,0.90 [0.43-1.91],0.7904050782360021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16390,71,2.37 [1.48-3.77],0.0002918870629992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,16698,73,0.92 [0.63-1.35],0.6729707681780988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,14009,59,0.83 [0.31-2.23],0.709232374515873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,13939,61,1.16 [0.76-1.76],0.4986039671403902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,14386,64,0.99 [0.50-1.98],0.9875123208388704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,14431,63,1.04 [0.80-1.36],0.7660952456735102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,13994,60,1.36 [0.89-2.09],0.1604458733087523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,14148,64,0.97 [0.60-1.55],0.8846420602374985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,14149,63,0.85 [0.59-1.22],0.3775928185978447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,14064,63,1.19 [0.87-1.65],0.2779608033860399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,16459,71,0.94 [0.74-1.19],0.5942616519404997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,14386,64,1.19 [0.86-1.67],0.2965904880415048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,14421,64,2.54 [1.95-3.31],4.245804206276252e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,13973,61,0.97 [0.72-1.30],0.8176110149125461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,16237,71,1.06 [0.84-1.32],0.6289589276785825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,16187,69,1.07 [0.72-1.59],0.7331511990750721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,16237,71,0.78 [0.49-1.24],0.2982710645529712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,14009,59,0.95 [0.71-1.27],0.7339804381867547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,16497,71,0.89 [0.69-1.16],0.3896899425424949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,16289,70,2.08 [0.98-4.40],0.0557032871316186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,14451,64,0.88 [0.63-1.23],0.4582181775245764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16459,71,1.22 [0.42-3.55],0.7147872762460922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,13994,60,1.04 [0.81-1.34],0.7595655754516938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16597,72,3.65 [1.88-7.09],0.0001340345701873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,16661,72,1.71 [0.88-3.35],0.1152048784393593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,13939,61,0.99 [0.73-1.33],0.933520362595514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,16658,73,0.80 [0.55-1.17],0.2535166968768137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,14009,59,0.46 [0.19-1.11],0.0857848403281417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,16598,73,0.65 [0.45-0.95],0.0242798930735961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,16676,73,0.99 [0.57-1.72],0.963153486243514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,14413,64,1.09 [0.50-2.38],0.8211835430911705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,16237,71,0.87 [0.75-1.01],0.0631410135740518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,14076,62,0.84 [0.29-2.44],0.7493727938305944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,14431,63,1.08 [0.57-2.06],0.8118660200248056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,16459,71,1.13 [0.82-1.56],0.4454098679158335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,14451,64,1.23 [0.87-1.74],0.2493241721976002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,16459,71,1.02 [0.64-1.62],0.93368146953701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,14178,64,0.84 [0.57-1.24],0.386712549375948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,16459,71,0.98 [0.75-1.28],0.8939941523815396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,14386,64,0.91 [0.70-1.18],0.479633755017678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,16459,71,0.96 [0.73-1.26],0.7723976102455197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,14386,64,1.09 [0.55-2.19],0.7988102236179214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,13973,61,0.99 [0.47-2.09],0.9889071267130346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,14386,64,0.79 [0.53-1.19],0.265820197600585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,16534,73,1.40 [0.86-2.28],0.1737770670740779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16493,72,0.83 [0.58-1.19],0.3062267575586918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,14421,64,1.17 [0.63-2.18],0.6156178326313038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,16155,71,0.91 [0.59-1.39],0.6501998176568224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,14178,64,1.20 [0.74-1.95],0.4608874836407562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16237,71,0.75 [0.50-1.12],0.1585720647769336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16661,72,0.91 [0.68-1.22],0.524767166845679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,16187,69,0.60 [0.30-1.23],0.1672795944413446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14149,63,0.92 [0.59-1.42],0.6911413393307473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,16659,73,1.37 [0.84-2.24],0.2115175549840212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,13939,61,0.84 [0.57-1.23],0.3695847009929479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,16333,71,1.14 [0.67-1.94],0.6250607172846693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,14413,64,0.75 [0.39-1.43],0.3745125598654223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,16740,73,1.45 [1.10-1.91],0.008389161160944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",16551,73,1.70 [1.00-2.89],0.0496675835144715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,16244,70,1.11 [0.82-1.52],0.496925469683004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,16237,71,0.96 [0.76-1.21],0.7399017001798953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,16155,71,1.01 [0.78-1.30],0.963454732145498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,14421,64,0.99 [0.72-1.36],0.936787269570113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,14009,59,0.72 [0.44-1.17],0.1821718449406001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,14386,64,3.51 [2.89-4.25],5.350335824776018e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,14080,63,1.02 [0.67-1.57],0.916243794328594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,16668,73,0.89 [0.64-1.24],0.4888836514678683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,15726,70,1.65 [1.02-2.67],0.0416293247971997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16337,70,1.74 [1.06-2.85],0.0272882711439592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16550,71,1.02 [0.55-1.89],0.959099266695709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,16689,73,1.17 [0.64-2.16],0.6065718486202933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,16244,70,1.11 [0.54-2.31],0.7752817478133787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16390,71,1.06 [0.71-1.58],0.7652267955675354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,16689,73,1.44 [1.07-1.93],0.0146740963493646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,16665,72,1.51 [0.80-2.82],0.2008205853564965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,14009,59,1.17 [0.76-1.80],0.4746449872339959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,16598,73,1.03 [0.84-1.27],0.744279152582213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,16155,71,1.40 [0.85-2.29],0.184058230585639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,14421,64,1.37 [0.58-3.20],0.4704929546017303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14372,64,0.96 [0.81-1.12],0.5830161944251444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,16459,71,0.94 [0.78-1.13],0.483480847303349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,14386,64,2.13 [1.26-3.59],0.0047315153522825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,13973,61,1.38 [0.94-2.02],0.0952664001490001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,16244,70,0.95 [0.74-1.23],0.7165224842262826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,14149,63,0.94 [0.67-1.31],0.702789065231717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,14009,59,1.11 [0.46-2.69],0.8146325243983832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,14009,59,2.42 [1.78-3.30],1.8830599901195e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,16187,69,0.87 [0.64-1.19],0.3811569757131143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,16237,71,2.25 [1.84-2.73],8.078219675171478e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,13973,61,1.28 [0.94-1.75],0.1167017411315328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,14372,64,0.99 [0.76-1.30],0.9415748191531342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,14421,64,2.70 [2.25-3.23],5.7149579794642236e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,14009,59,1.09 [0.59-2.01],0.7875396267177456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,14178,64,1.06 [0.73-1.53],0.7723733273198283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,14386,64,0.70 [0.46-1.06],0.0897261710512289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,14372,64,1.28 [0.92-1.77],0.1407561495050597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14386,64,0.76 [0.47-1.21],0.2479928508889251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,14076,62,0.93 [0.85-1.02],0.1045498031209492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,13939,61,0.50 [0.18-1.37],0.1777022573252139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,13994,60,0.73 [0.51-1.05],0.0896918530954889
